<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?properties manuscript?><?origin nihpa?><?iso-abbr Nat. Med.?><?submitter-system nihms?><?submitter-canonical-name Nature Publishing Group?><?submitter-canonical-id NATURE-STRUCTUR?><?submitter-userid 8068858?><?submitter-authority myNCBI?><?submitter-login nature-structure?><?submitter-name Nature Publishing Group?><?domain nihpa?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">9502015</journal-id><journal-id journal-id-type="pubmed-jr-id">8791</journal-id><journal-id journal-id-type="nlm-ta">Nat Med</journal-id><journal-id journal-id-type="iso-abbrev">Nat. Med.</journal-id><journal-title-group><journal-title>Nature medicine</journal-title></journal-title-group><issn pub-type="ppub">1078-8956</issn><issn pub-type="epub">1546-170X</issn></journal-meta><article-meta><article-id pub-id-type="pmcid">4974139</article-id><article-id pub-id-type="pmid">27348499</article-id><article-id pub-id-type="doi">10.1038/nm.4130</article-id><article-id pub-id-type="manuscript">nihpa789731</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>The Inhibition of TDP-43 Mitochondrial Localization Blocks Its Neuronal Toxicity </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Wenzhang</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref rid="FN2" ref-type="author-notes">7</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Luwen</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref rid="FN2" ref-type="author-notes">7</xref></contrib><contrib contrib-type="author"><name><surname>Lu</surname><given-names>Junjie</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref rid="FN2" ref-type="author-notes">7</xref></contrib><contrib contrib-type="author"><name><surname>Siedlak</surname><given-names>Sandra L.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fujioka</surname><given-names>Hisashi</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Liang</surname><given-names>Jingjing</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Sirui</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ma</surname><given-names>Xiaopin</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Zhen</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>da Rocha</surname><given-names>Edroaldo Lummertz</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Sheng</surname><given-names>Max</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Choi</surname><given-names>Heewon</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Lerou</surname><given-names>Paul H.</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Hu</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Xinglong</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>Departments of Pathology, Case Western Reserve University, Cleveland, OH, USA</aff><aff id="A2"><label>2</label>Department of Pediatric Newborn Medicine, Brigham &amp; Women’s Hospital, Boston, MA, USA</aff><aff id="A3"><label>3</label>Electron Microscopy Core Facility, Case Western Reserve University, Cleveland, OH, USA</aff><aff id="A4"><label>4</label>Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA</aff><aff id="A5"><label>5</label>Department of Molecular Pharmacology &amp; Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA</aff><aff id="A6"><label>6</label>Department of Pediatrics, Massachusetts General Hospital, Boston, MA, USA</aff><author-notes><corresp id="FN1">Correspondence to: Xinglong Wang (<email>xinglong.wang@case.edu</email>)</corresp><fn id="FN2" fn-type="equal"><label>7</label><p><text><SENT sid="1" pm="."><plain>These authors contributed equally to this work. </plain></SENT>
</text></p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>1</day><month>6</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>27</day><month>6</month><year>2016</year></pub-date><pub-date pub-type="ppub"><month>8</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>27</day><month>12</month><year>2016</year></pub-date><volume>22</volume><issue>8</issue><fpage>869</fpage><lpage>878</lpage><permissions><license><license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:
<uri xlink:type="simple" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</uri></license-p></license></permissions><abstract><p id="P1"><SecTag type="ABS"><text><SENT sid="2" pm="."><plain>Genetic mutations in TAR DNA-binding protein 43 (TDP-43) cause amyotrophic lateral sclerosis (ALS), and the increased presence of TDP-43 in the cytoplasm is a prominent histopathological feature of degenerating neurons in various neurodegenerative diseases. </plain></SENT>
<SENT sid="3" pm="."><plain>However, the molecular mechanisms by which TDP-43 contributes to ALS pathophysiology remain elusive. </plain></SENT>
<SENT sid="4" pm="."><plain>Here, we have found that TDP-43 accumulates in mitochondria in neurons of subjects with ALS or frontotemporal dementia (FTD). </plain></SENT>
<SENT sid="5" pm="."><plain>Disease-associated mutations increase TDP-43 mitochondrial localization. </plain></SENT>
<SENT sid="6" pm="."><plain>Within mitochondria, wild type (WT) and mutant TDP-43 preferentially bind mitochondria-transcribed messenger RNAs (mRNAs) encoding respiratory complex I subunit ND3 and ND6, impair their expression and specifically cause complex I disassembly. </plain></SENT>
<SENT sid="7" pm="."><plain>Suppression of TDP-43 mitochondrial localization abolishes WT and mutant TDP-43-induced mitochondrial dysfunction and neuronal loss, and improves phenotypes of transgenic mutant TDP-43 mice. </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, our studies link TDP-43 toxicity directly to mitochondrial bioenergetics and propose targeting TDP-43 mitochondrial localization as a promising therapeutic approach for neurodegeneration. </plain></SENT>
</text></SecTag></p></abstract></article-meta></front><body><SecTag type="INTRO"><sec sec-type="intro" id="S1"><title><text><SENT sid="9" pm="."><plain>Introduction </plain></SENT>
</text></title><p id="P2"><text><SENT sid="10" pm="."><plain>ALS is the most common motor disease characterized by progressive motor neuron degeneration in the brain stem and spinal cord1, while FTD is the second most common form of early-onset dementia caused by neuron loss in the frontal and temporal cortex2. </plain></SENT>
<SENT sid="11" pm="."><plain>The vast majority of ALS or FTD cases, referred to as sporadic ALS or FTD, are not genetically transmitted and their causes remain unknown. </plain></SENT>
<SENT sid="12" pm="."><plain>Currently, there is no effective treatment for both ALS and FTD. </plain></SENT>
</text></p><p id="P3"><text><SENT sid="13" pm="."><plain>TDP-43 (also named TARDBP) is a small ubiquitously expressed RNA and DNA binding protein containing two tandem RNA recognition motifs RRM1 and RRM23. </plain></SENT>
<SENT sid="14" pm="."><plain>Previous studies have revealed that TDP-43 primarily binds mRNA and regulates post-transcriptional RNA processing, including RNA splicing, transportation and translation4–6. </plain></SENT>
<SENT sid="15" pm="."><plain>Autosomal dominant mutations in TDP-43 are associated with sporadic and familial ALS7,8, and the redistribution of TDP-43 from the nucleus to cytoplasm has been recognized as a pathological hallmark for most forms of ALS and most frequent subtypes of FTD9,10. </plain></SENT>
<SENT sid="16" pm="."><plain>In fact, the mis-localization of TDP-43 to the cytoplasm also represents a key pathological feature of other major neurodegenerative diseases including Alzheimer’s disease11,12, Parkinson’s disease13 and Huntington’s disease14. </plain></SENT>
</text></p><p id="P4"><text><SENT sid="17" pm="."><plain>It still remains controversial whether loss of TDP-43 function via nuclear depletion or gain of function by adverse effect of cytoplasmic TDP-43 causes neuronal loss in ALS and FTD. </plain></SENT>
<SENT sid="18" pm="."><plain>Interestingly, previous studies have revealed that nuclear depletion is not required for TDP-43 neuronal toxicity15,16, and cytoplasmic TDP-43 is sufficient to cause neurodegeneration17, suggesting an important role of cytoplasmic TDP-43 in disease progress. </plain></SENT>
<SENT sid="19" pm="."><plain>However, both the pathogenic mechanisms of cytoplasmic TDP-43, as well as its subcellular organelle targets, remain largely unknown. </plain></SENT>
</text></p></sec></SecTag><SecTag type="RESULTS"><sec sec-type="results" id="S2"><title><text><SENT sid="20" pm="."><plain>Results </plain></SENT>
</text></title><sec id="S3"><title><text><SENT sid="21" pm="."><plain>TDP-43 accumulates in mitochondria in ALS and FTD </plain></SENT>
</text></title><p id="P5"><text><SENT sid="22" pm="."><plain>We first investigated the co-localization of TDP-43 with various neuronal organelles in human spinal cord and frontal cortex tissue samples obtained from ALS and FTD cases, respectively, compared to age-matched normal individuals. </plain></SENT>
<SENT sid="23" pm="."><plain>Both spinal cord motor neurons and cortical neurons in the control cases demonstrated mainly nuclear TDP-43 localization, while both ALS motor neurons and FTD cortical neurons showed characteristically high levels of cytoplasmic TDP-43 accumulation (Fig. 1a–d). </plain></SENT>
<SENT sid="24" pm="."><plain>Notably, cytoplasmic TDP-43 co-localized with mitochondrial markers in many ALS spinal cord motor neurons or FTD cortical neurons, but minimally overlapped with markers of Golgi, endoplasmic reticulum, lysosome, autophagosome, endosome or peroxisome (Fig. 1a–d and Supplementary Fig. 1). </plain></SENT>
<SENT sid="25" pm="."><plain>Despite low abundance, cytoplasmic TDP-43 in control human motor neurons and cortical neurons also significantly co-localized with mitochondria (Fig. 1a–d and Supplementary Fig. 1). </plain></SENT>
</text></p><p id="P6"><text><SENT sid="26" pm="."><plain>We further isolated highly purified mitochondria with preserved membranes from human spinal cord and cortical tissues (Supplementary Fig. 2a,b), and found TDP-43 present in mitochondria from all samples (Fig. 1e,f). </plain></SENT>
<SENT sid="27" pm="."><plain>There was a markedly higher expression of TDP-43 in mitochondria from ALS or FTD than from age-matched controls. </plain></SENT>
<SENT sid="28" pm="."><plain>Subsequent sub-mitochondrial fractionation analysis revealed that mitochondrial TDP-43 was exclusively present in the inner mitochondrial membrane (IMM) but not in outer mitochondrial membrane (OMM), intermembrane-space (IMS) or matrix (Fig. 1g,h). </plain></SENT>
<SENT sid="29" pm="."><plain>Immuno-electron microscopy (immuno-EM) analysis of isolated mitochondria and biopsied human cortex confirmed the main localization of TDP-43 in IMM cristae (Fig. 1i and Supplementary Fig. 2c). </plain></SENT>
<SENT sid="30" pm="."><plain>Mitochondria from ALS spinal cords or FTD cortices exhibited more TDP-43 labeling than those from age-matched controls. </plain></SENT>
<SENT sid="31" pm="."><plain>We also isolated mitochondria from freshly collected mouse tissue samples of spinal cord and cortex, and treated them with trypsin and digitonin to permeabilize OMM but not IMM. </plain></SENT>
<SENT sid="32" pm="."><plain>OMM-proteins MFN2 and MFF were digested by trypsin alone, IMS facing IMM proteins TIM23 and OPA1 were digested by trypsin after OMM permeabilization, while TDP-43 or matrix facing IMM proteins COXIV and F1β (also named ATP5B) remained unchanged under all these conditions (Supplementary Fig. 2d). </plain></SENT>
<SENT sid="33" pm="."><plain>Like COXIV and F1β, TDP-43 could be digested by trypsin after complete membrane permeabilization via triton X-100. </plain></SENT>
<SENT sid="34" pm="."><plain>TDP-43 also exclusively resides in the IMM fraction of mouse mitochondria (Supplementary Fig. 2e). </plain></SENT>
</text></p></sec><sec id="S4"><title><text><SENT sid="35" pm="."><plain>ALS-mutations increase TDP-43 mitochondrial localization </plain></SENT>
</text></title><p id="P7"><text><SENT sid="36" pm="."><plain>We next determined whether disease-associated mutations in TDP-43 affected its mitochondrial localization. </plain></SENT>
<SENT sid="37" pm="."><plain>We first examined TDP-43 expression in mitochondria isolated from primary human fibroblasts derived from ALS patients bearing TDP-43 mutation G298S or A382T (G298S or A382T fibroblasts) and age-matched normal human individuals (normal human fibroblasts, NHFs). </plain></SENT>
<SENT sid="38" pm="."><plain>TDP-43 mutations in G298S and A382T fibroblasts were confirmed by genomic DNA sequencing (Supplementary Fig. 2f). </plain></SENT>
<SENT sid="39" pm="."><plain>Similar to NHFs, G298S and A382T fibroblasts exhibited the predominantly nuclear localization of TDP-43 without cytoplasmic accumulation (Supplementary Fig. 2g). </plain></SENT>
<SENT sid="40" pm="."><plain>Whereas all fibroblasts displayed comparable expression of total TDP-43 (Supplementary Fig. 2h), G298S and A382T fibroblasts demonstrated significantly higher levels of mitochondrial TDP-43 than NHFs (Fig 2a and Supplementary Fig. 2i). </plain></SENT>
<SENT sid="41" pm="."><plain>We also compared WT and mutant TDP-43 mitochondrial localization in HEK293 cells or brain and spinal cord tissue samples from transgenic mice overexpressing WT or mutant human TDP-43. </plain></SENT>
<SENT sid="42" pm="."><plain>Consistently, despite similar levels in total lysates, exogenously expressed human G298S, A315T or A382T TDP-43 showed greater mitochondrial expression than human WT TDP-43 (Fig. 2b,c). </plain></SENT>
<SENT sid="43" pm="."><plain>Exogenously expressed or endogenous human WT and mutant TDP-43 were still present in IMM fraction (Fig. 2d,e) and digestible by trypsin after IMM but not OMM permeabilization (not shown). </plain></SENT>
</text></p><p id="P8"><text><SENT sid="44" pm="."><plain>We then employed a cell-free mitochondrial import assay using Flag-tagged recombinant WT/mutant human TDP-43 protein (rTDP-43) and isolated mouse brain mitochondria. </plain></SENT>
<SENT sid="45" pm="."><plain>All human rTDP-43 were soluble, uncleaved and unmodified post-translationally (not shown). </plain></SENT>
<SENT sid="46" pm="."><plain>The widely used biotin-labeled recombinant F1β precursor protein (pF1β) was included as a positive control18, while recombinant GFP was employed as a negative control (not shown). </plain></SENT>
<SENT sid="47" pm="."><plain>pF1β contained a cleavable signal sequence which was cleaved off after import to generate the shorter mF1β (Fig. 2f). </plain></SENT>
<SENT sid="48" pm="."><plain>Similar to mF1β, WT rTDP-43 survived digitonin/trypsin co-treatment after import (Fig. 2f), demonstrating the successful import to the innards of IMM. </plain></SENT>
<SENT sid="49" pm="."><plain>Compared with WT rTDP-43, rTDP-43 bearing G298S, A315T or A382T, demonstrated higher import efficiency (Fig. 2g). </plain></SENT>
<SENT sid="50" pm="."><plain>Imported WT and mutant rTDP-43 could both be completely digested by trypsin after triton X-100 permeabilization (not shown). </plain></SENT>
<SENT sid="51" pm="."><plain>Further immuno-EM analysis confirmed the IMM cristae localization of imported WT and mutant rTDP-43 as well as the greater import of disease-associated mutant rTDP-43 compared to WT (Fig. 2h). </plain></SENT>
</text></p></sec><sec id="S5"><title><text><SENT sid="52" pm="."><plain>TDP-43 mitochondrial localization depends on internal motifs </plain></SENT>
</text></title><p id="P9"><text><SENT sid="53" pm="."><plain>TDP-43 remains uncleaved after import and no cleavable pre-sequence is identified in TDP-43 by TargetP19 or Mitoprot20, suggesting TDP-43 might use internal signals21. </plain></SENT>
<SENT sid="54" pm="."><plain>Mitochondrial internal signals are typically composed of a stretch of continuous hydrophobic amino acids22, and six such stretches are present in TDP-43 (Fig. 3a, M1–6). </plain></SENT>
<SENT sid="55" pm="."><plain>The deletions of M1, M3 or M5 significantly inhibited rTDP-43 import, and reduced mitochondrial localization of exogenously expressed TDP-43 (Fig. 3b,c). </plain></SENT>
<SENT sid="56" pm="."><plain>Since M1 and M3 segments were conserved across species (Supplementary Fig. 3a), we synthesized two peptides PM1 (YGRKKRRQRRRAQFPGACGL) and PM3 (YGRKKRRQRRRSKGFGFVRF) in which the M1 or M3 motif was fused to a TAT peptide to enhance permeability23. </plain></SENT>
<SENT sid="57" pm="."><plain>PM1 and PM3, but not control peptides cPMs (mixture of YGRKKRRQRRRAAQGFGCPL and YGRKKRRQRRRGRFFKSFG, scrambled M1 and M3 fused to TAT respectively), suppressed rTDP-43 import, and reduced mitochondrial TDP-43 in HEK293 cells and primary neurons (Fig. 3d–f). </plain></SENT>
<SENT sid="58" pm="."><plain>The fusion of M3, M5 and especially M1 with the unrelated cytosolic protein GFP (green fluorescent protein) was sufficient to facilitate its mitochondrial targeting (Fig. 3g and Supplementary Fig. 3b). </plain></SENT>
</text></p></sec><sec id="S6"><title><text><SENT sid="59" pm="."><plain>Mitochondrial TDP-43 inhibits translation of ND3/6 mRNAs </plain></SENT>
</text></title><p id="P10"><text><SENT sid="60" pm="."><plain>The IMM residence of TDP-43 prompted us to examine whether TDP-43 bound mitochondria-transcribed mRNAs (Fig. 4a). </plain></SENT>
<SENT sid="61" pm="."><plain>RNA immunoprecipitation (IP) with or without prior cross-linking using mouse brain mitochondria found that TDP-43, but not the RNA-binding-domain lacking negative control COXIV (not shown), significantly pulled down ND3, ND5, ND6, COXI, COXIII, CYTB and A6 mRNAs, while other mRNAs were only slightly enriched at levels comparable to 12s or 16s rRNAs (Fig. 4b). </plain></SENT>
<SENT sid="62" pm="."><plain>All mutant versions of TDP-43 precipitated similar mRNAs with comparable abundance as WT TDP-43 (Fig. 4c,d). </plain></SENT>
</text></p><p id="P11"><text><SENT sid="63" pm="."><plain>Mitochondrial-transcribed mRNA levels are not affected by TDP-43 over-expression (Supplementary Fig. 3c). </plain></SENT>
<SENT sid="64" pm="."><plain>We investigated the effect of TDP-43 on mitochondrial translation in HEK293 cells by the azidohomoalanine (AHA) incorporation assay in the presence of emetine to block cytosolic translation. </plain></SENT>
<SENT sid="65" pm="."><plain>The synthesis of ND3/6 was significantly reduced by WT TDP-43 overexpression (Fig. 4e), consistent with the preferential binding of TDP-43 to their mRNAs. </plain></SENT>
<SENT sid="66" pm="."><plain>The steady state levels of ND3/6, but not most mitochondrial-encoded subunits of oxidative phosphorylation (OXPHOS) complexes, were indeed decreased by WT TDP-43 (Fig. 4f). </plain></SENT>
<SENT sid="67" pm="."><plain>The WT TDP-43-induced reduction in the synthesis or expression of ND3/6 could be blocked by M1 deletion. </plain></SENT>
<SENT sid="68" pm="."><plain>TDP-43 has no global effect on the translation of all mitochondria-encoded proteins (Fig. 4e, f). </plain></SENT>
<SENT sid="69" pm="."><plain>TDP-43 expression did not alter the sedimentation patterns of MRPS18B and MRPL44 (mitochondrial ribosome 28S/39S subunit marker) in sucrose gradients of isolated mitochondria, suggesting no effect on overall mitochondrial ribosome assembly (Supplementary Fig. 3d). </plain></SENT>
<SENT sid="70" pm="."><plain>However, further RNA distribution analysis found that, in contrast to a high degree of sedimentation with 55S ribosomal complex in control cells, additional peaks of ND3/6, but not COXI, mRNA between 28S and 55S complexes could be induced by WT TDP-43, but not ΔM1, overexpression (Supplementary Fig. 3e). </plain></SENT>
</text></p><p id="P12"><text><SENT sid="71" pm="."><plain>Compared with WT TDP-43, all mutant TDP-43s caused further reductions of ND3/6 expression (Fig. 4f, g). </plain></SENT>
<SENT sid="72" pm="."><plain>Notably, M1 deletion or treatment with PM1 increased ND3/6 expression to levels similar to control cells or NHFs. </plain></SENT>
<SENT sid="73" pm="."><plain>PM3 was not tested because of the localization of M3 in the TDP-43 RNA binding motif (Fig. 3a) and the mild toxic effect of PM3 on cells (not shown). </plain></SENT>
<SENT sid="74" pm="."><plain>Compared with aged matched control human tissues, ALS spinal cords or FTD cortices exhibited reduced expression of ND3/6 (Fig. 4h and Supplementary Fig. 3f). </plain></SENT>
</text></p></sec><sec id="S7"><title><text><SENT sid="75" pm="."><plain>Mitochondrial TDP-43 impairs OXPHOS complex I </plain></SENT>
</text></title><p id="P13"><text><SENT sid="76" pm="."><plain>Consistent with the specific inhibitory effect of TDP-43 on the expression of complex I subunits ND3/6, WT TDP-43 overexpression caused a significant reduction of complex I expression and function, as well as a slight disassembly of complex I-comprised supercomplexes. </plain></SENT>
<SENT sid="77" pm="."><plain>These effects were exacerbated by overexpression of G298S, A315T or A382T mutant TDP-43, but prevented by M1 deletion (Fig. 5a,b and Supplementary Fig. 4a,b). </plain></SENT>
<SENT sid="78" pm="."><plain>The disassembly and dysfunction of complex I was also observed in G298S or A382T fibroblasts, and PM1 treatment significantly restored complex I assembly and function to levels comparable to NHFs (Fig. 5c,d). </plain></SENT>
<SENT sid="79" pm="."><plain>Interestingly, TDP-43-induced complex I disassembly and dysfunction could also be alleviated by the simultaneous overexpression of both ND3 and ND6 but not ND3 or ND6 individually (Supplementary Fig. 4c and Fig. 5e). </plain></SENT>
</text></p><p id="P14"><text><SENT sid="80" pm="."><plain>Significant mitochondrial dysfunction (including reduced mitochondrial membrane potential (mΔψ), oxygen consumption rate (OCR) and ATP levels) accompanied by mitochondrial fragmentation were all observed in HEK293 cells overexpressing WT or mutant TDP-43 (Supplementary Fig. 4d), and in G298S/A382T fibroblasts (Fig. 5f,g). </plain></SENT>
<SENT sid="81" pm="."><plain>Compared with WT TDP-43, mutant TDP-43 caused more severe mitochondrial abnormalities. </plain></SENT>
<SENT sid="82" pm="."><plain>WT or mutant TDP-43-induced mitochondrial dysfunction and fragmentation could be completely prevented by M1 deletion or PM1 treatment. </plain></SENT>
<SENT sid="83" pm="."><plain>Notably, although no basal cell death was observed, G298S/A382T fibroblasts exhibited increased vulnerability to oxidative stress compared with NHFs, which could also be abolished by PM1 treatment (Fig. 5h). </plain></SENT>
</text></p></sec><sec id="S8"><title><text><SENT sid="84" pm="."><plain>Mitochondrial localization is critical for TDP-43 toxicity </plain></SENT>
</text></title><p id="P15"><text><SENT sid="85" pm="."><plain>WT TDP-43 overexpression resulted in mitochondrial fragmentation and dysfunction preceding neuronal death in cultured rat primary neurons, all of which were exacerbated by G298S, A315T or A382T, but completely abolished by M1 deletion or PM1 treatment (Supplementary Fig. 5). </plain></SENT>
<SENT sid="86" pm="."><plain>We also reprogrammed NHFs and A382T fibroblast to induced-pluripotent stem cells (iPSCs) followed by sequentially differentiation into induced neuronal progenitor cells (iNPCs) and human neurons (control and A382T human neurons, Supplementary Fig. 6a–e). </plain></SENT>
<SENT sid="87" pm="."><plain>Both control and A382T human neurons were indistinguishable in TDP-43 nuclear localization, neuronal morphology and viability (Supplementary Fig. 6f,g). </plain></SENT>
<SENT sid="88" pm="."><plain>However, compared with control human neurons, A382T human neurons exhibited significant mitochondrial fragmentation/dysfunction and increased vulnerability to oxidative stress, which could be alleviated by PM1 treatment (Supplementary Fig. 6g–i). </plain></SENT>
<SENT sid="89" pm="."><plain>As expected, M1 deletion was also sufficient to abolish mitochondrial abnormalities and neuronal death induced by TDP-43 WT or A315T overexpression in control human neurons (Supplementary Fig. 6j). </plain></SENT>
</text></p><p id="P16"><text><SENT sid="90" pm="."><plain>Neuron-specific bicistronic lentiviruses encoding both TDP-43 and mitoDsRed2 were stereotactically injected into mouse cortices (Fig. 6a). </plain></SENT>
<SENT sid="91" pm="."><plain>Compared with WT TDP-43, TDP-43 A315T caused further mitochondria fragmentation and increased neuronal death (evidenced by cleaved caspase-3 staining), which could be blocked by M1 deletion (Fig. 6b,c). </plain></SENT>
<SENT sid="92" pm="."><plain>While neurodegeneration has been consistently reported in TDP-43 A315T hemizygous transgenic mice, but not in TDP-43 WT hemizygous transgenic mice24–28, both exhibited similar human TDP-43 expression (Fig. 2c). </plain></SENT>
<SENT sid="93" pm="."><plain>We treated TDP-43 A315T mice with PM1 by continuous subcutaneous infusion and confirmed that PM1 reached the central nervous system and substantially reduced mutant TDP-43 in mitochondria (Supplementary Fig. 7a–c). </plain></SENT>
<SENT sid="94" pm="."><plain>PM1 could be detected in all mitochondrial compartments (Supplementary Fig. 7d). </plain></SENT>
<SENT sid="95" pm="."><plain>Consistent with the significant protective effect against the reduction in ND3/6 expression, mΔψ/OCR and complex I assembly (Fig. 6d–f), PM1 almost completely prevented the loss of cortical and motor neuron cell bodies, axons and/or synapses (evidenced by denervated neuromuscular junction (NMJ)) in TDP-43 A315T mice (Fig. 6g,h and Supplementary Fig. 7e,f). </plain></SENT>
<SENT sid="96" pm="."><plain>Interestingly, mitochondrial fragmentation and neuropathologies such as phospho-TDP-43 positive inclusions and astrogliosis in TDP-43 A315T mice disappeared after PM1 infusion (Supplementary Fig. 7g–j). </plain></SENT>
<SENT sid="97" pm="."><plain>Remarkably, skeletal muscle atrophy and phenotypes (including gait abnormality, impaired performance on rotarod and movement defects) noted in TDP-43 A315T mice, could also be alleviated by PM1 and restored to levels comparable to non-transgenic WT mice (Fig. 6i,j, Supplementary Fig. 8 and Supplementary Movie 1–3). </plain></SENT>
<SENT sid="98" pm="."><plain>Of note, the deletion of M1 has no effect on TDP-43 half-life, dimerization or its binding to non-mitochondrial mRNA targets (Supplementary Fig. 9a–d). </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="DISCUSS"><sec sec-type="discussion" id="S9"><title><text><SENT sid="99" pm="."><plain>Discussion </plain></SENT>
</text></title><p id="P17"><text><SENT sid="100" pm="."><plain>Consistent with a previous ultrastructural study29, here we show that some TDP-43 accumulates in mitochondria in ALS/FTD. </plain></SENT>
<SENT sid="101" pm="."><plain>TDP-43 aggregation, cleavage, ubiquitination and phosphorylation were reported in ALS/FTD9,30. </plain></SENT>
<SENT sid="102" pm="."><plain>Despite being highly phosphorylated, mitochondrial TDP-43 is soluble and uncleaved (Supplementary Fig. 9e–g). </plain></SENT>
<SENT sid="103" pm="."><plain>Phospho-TDP-43-positive inclusions highly co-localize with mitochondria, ubiquitin-positive inclusions or compact/skein-like TDP-43 inclusions partially overlap, and mitochondrial co-localized TDP-43 shows little ubiquitination (Supplementary Fig. 9h,i). </plain></SENT>
<SENT sid="104" pm="."><plain>Since TDP-43 pre-inclusions are reportedly highly phosphorylated but not ubiquitinated29,31, mitochondria associated TDP-43 likely represents this pre-inclusion population of pathologic TDP-43. </plain></SENT>
<SENT sid="105" pm="."><plain>G298S is present in the M5 motif, and compared with G298S, phosphorylation-mimicking mutant G298D causes further increase of mitochondrial localization, whereas phosphorylation-ablation mutant G298A exhibited similar mitochondrial localization as WT TDP-43 (Supplementary Fig. 9j). </plain></SENT>
<SENT sid="106" pm="."><plain>It is worth investigating whether other disease-associated TDP-43 mutations residing within/out of mitochondrial internal motifs also increase its mitochondrial localization through phosphorylation. </plain></SENT>
</text></p><p id="P18"><text><SENT sid="107" pm="."><plain>Similar to ALS/FTD neurons, cultured neurons expressing mutant TDP-43 exhibited TDP-43 mis-localization and formation of puncta in cell bodies and neurites co-localized with mitochondria (Supplementary Fig. 10a–d). </plain></SENT>
<SENT sid="108" pm="."><plain>Both were abolished by M1 deletion or PM1 treatment, suggesting mitochondrial TDP-43 as a possible upstream regulator of TDP-43 mislocalization. </plain></SENT>
<SENT sid="109" pm="."><plain>However, as TDP-43 deficiency alone is sufficient to cause neuronal loss32,33, the contribution of TDP-43 nuclear depletion to mitochondrial TDP-43 accumulation could not be ruled out. </plain></SENT>
<SENT sid="110" pm="."><plain>TDP-43 with inactivated nuclear localization signal significantly co-localizes with mitochondria (Supplementary Fig. 10e), indicating mitochondrial localization as an intrinsic property of cytoplasmic TDP-43. </plain></SENT>
<SENT sid="111" pm="."><plain>TDP-43 binds mitochondria-transcribed mRNA and regulates mitochondrial translation. </plain></SENT>
<SENT sid="112" pm="."><plain>Mitochondrial translation machinery resides in immediate proximity to matrix-facing IMM34. </plain></SENT>
<SENT sid="113" pm="."><plain>Therefore, the matrix-facing IMM localization of TDP-43 supports its functional role inside mitochondria. </plain></SENT>
<SENT sid="114" pm="."><plain>IMM proteins with internal sequences are imported across OMM through TOM complex via TOM70 and across IMM by TIM22 complex22. </plain></SENT>
<SENT sid="115" pm="."><plain>As expected, TIM22, but not TIM23, co-precipitated TDP-43, and knockdown of TIM22, but not TIM23, significantly reduced TDP-43 mitochondrial localization (Supplementary Fig. 10f,g). </plain></SENT>
<SENT sid="116" pm="."><plain>These results, together with the finding that both TOM20 and TOM70 co-precipitated TDP-43, indicate TDP-43 mitochondrial import depends on TOM/TIM22 complex. </plain></SENT>
<SENT sid="117" pm="."><plain>TDP-43 import depends on Δψ (Supplementary Fig. 10h). </plain></SENT>
<SENT sid="118" pm="."><plain>Considering molecular chaperones are usually needed to unfold protein before and during import22, perhaps the final localization of TDP-43 in mitochondria depends on multiple factors including but not limited to TOM/TIM22 complexes, Δψ and chaperones. </plain></SENT>
</text></p><p id="P19"><text><SENT sid="119" pm="."><plain>Recombinant TDP-43 could bind ND3 probe, with diminished efficiency when all G/U(s) in UG-repeats are mutated to A(s) (Supplementary Fig. 10i), suggesting previously identified UG-repeats35–38 as potential binding sites. </plain></SENT>
<SENT sid="120" pm="."><plain>TDP-43 mainly pulls down ND3/6 mRNAs and inhibits their translation. </plain></SENT>
<SENT sid="121" pm="."><plain>It can be expected that increased mitochondrial TDP-43 specifically causes complex I disassembly and dysfunction. </plain></SENT>
<SENT sid="122" pm="."><plain>Interestingly, mitochondrial TDP-43 impairs the mitochondrial ribosomes loading onto ND3/6 mRNAs, suggesting one possible mechanism by which TDP-43 regulates mitochondrial translation. </plain></SENT>
<SENT sid="123" pm="."><plain>The co-expression of both ND3/6 was sufficient to alleviate TDP-43-induced complex I disassembly and dysfunction, supporting ND3/6 as specific targets of TDP-43 in mitochondria. </plain></SENT>
<SENT sid="124" pm="."><plain>Indeed, mutations in ND3/6 are directly associated with neurological disorders and cause complex I deficiency39,40. </plain></SENT>
<SENT sid="125" pm="."><plain>Since assembly of respiratory complexes and mitochondrial dynamic are highly interrelated41,42 it is feasible that, in addition to regulating mitochondrial bioenergetics, TDP-43 could affect both mitochondrial morphology and movement43–46. </plain></SENT>
<SENT sid="126" pm="."><plain>TDP-43-induced mitochondrial fragmentation or trafficking deficit could be abolished by inhibiting its mitochondrial localization (Supplementary Fig. 11a–c), suggesting them as downstream effects. </plain></SENT>
<SENT sid="127" pm="."><plain>Mitochondrial trafficking deficit induced by TDP-43 could be alleviated by the inhibition of mitochondrial fragmentation46, indicating the impairment of mitochondrial movement possibly even downstream of mitochondrial fragmentation. </plain></SENT>
</text></p><p id="P20"><text><SENT sid="128" pm="."><plain>The physiological function of TDP-43 is still unclear. </plain></SENT>
<SENT sid="129" pm="."><plain>Either knockdown of TDP-43 or reduced mitochondrial TDP-43 by PM1 increases ND3/6 expression, but has no effect on other complex I subunits or complex I assembly (Supplementary Fig. 11d,e). </plain></SENT>
<SENT sid="130" pm="."><plain>Disease-associated mutations in TDP-43 do not change its IMM localization and binding efficiency to ND3/6 mRNAs. </plain></SENT>
<SENT sid="131" pm="."><plain>The toxicity of WT/mutant TDP-43 on mitochondria and neurons is likely due to excess mitochondrial TDP-43, which may explain why PM1 treatment, which reduced but did not completely abolish mitochondrial TDP-43, restored mitochondrial and neuronal function in A315T mice to levels comparable to NTG mice. </plain></SENT>
</text></p><p id="P21"><text><SENT sid="132" pm="."><plain>Mitochondrial dysfunction precedes TDP-43-induced neuronal death, and mitochondria are involved in almost all types of cell death including apoptosis and necrosis47,48. </plain></SENT>
<SENT sid="133" pm="."><plain>In cultured rat primary neurons overexpressing TDP-43, we found fewer cleaved caspase 3 positive neurons than SYTOX green positive neurons, suggesting possibly different types of neuronal death caused by TDP-43. </plain></SENT>
<SENT sid="134" pm="."><plain>Therefore, it is of further interest to investigate the potential role of mitochondrial dysfunction mediating TDP-43-induced neuronal death by apoptotic and non-apoptotic mechanisms. </plain></SENT>
<SENT sid="135" pm="."><plain>Unlike rat primary neurons, human neurons derived from A382T fibroblasts exhibit normal neuronal viability. </plain></SENT>
<SENT sid="136" pm="."><plain>Considering age or age-associated phenotypes is usually lost after fibroblast reprogramming49,50, it is possible that the level of mitochondrial TDP-43 in young iPSCs derived human neurons bearing A382T mutation is insufficient to reach the threshold to cause neuronal death, and age-dependent mitochondrial TDP-43 accumulation is required for mutant TDP-43 neuronal toxicity. </plain></SENT>
</text></p><p id="P22"><text><SENT sid="137" pm="."><plain>In sum, here we present a novel mechanism of TDP-43 toxicity wherein TDP-43 resides in mitochondria specifically impairing OXPHOS complex I via preferentially binding mitochondrial-transcribed ND3/6 mRNAs and inhibiting their translation to cause mitochondrial dysfunction and neurodegeneration (Supplementary Fig. 12). </plain></SENT>
<SENT sid="138" pm="."><plain>Notably, suppression of TDP-43 mitochondrial localization abolishes the toxicity of WT/mutant TDP-43 on mitochondria and neurons, thus providing the rationale for targeting TDP-43 mitochondrial localization as a new therapeutic approach for neurodegeneration linked to TDP-43. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="materials|methods" id="S10"><title><text><SENT sid="139" pm="."><plain>Materials and Methods </plain></SENT>
</text></title><sec id="S11"><title><text><SENT sid="140" pm="."><plain>Immunocytochemistry and immunofluorescence of mouse and human spinal cord </plain></SENT>
</text></title><p id="P23"><text><SENT sid="141" pm="."><plain>The use of all human tissue samples was approved by the University Hospitals Institutional Review Board (IRB) for human investigation at University Hospitals Case Medical Center at Cleveland. </plain></SENT>
<SENT sid="142" pm="."><plain>Human spinal cord tissues obtained postmortemly from University Hospitals of Cleveland were fixed and 6 μm-thick consecutive sections prepared as we described before51 (Table 1). </plain></SENT>
<SENT sid="143" pm="."><plain>Immunocytochemistry was performed by the peroxidase anti-peroxidase protocol51. </plain></SENT>
<SENT sid="144" pm="."><plain>For immunofluorescent staining, deparaffinized and re-hydrated tissue sections were washed briefly three times with distilled H2O and placed in 1X antigen decloaker (Biocare, Concord, CA). </plain></SENT>
<SENT sid="145" pm="."><plain>The sections were then subject to antigen retrieval under pressure using Biocare’s Decloaking Chamber by heating to125 °C for 10 sec and cooling to 90 °C for 30 sec followed by heating to 22 psi at 128 °C, and cooling to 0 psi at 94 °C. </plain></SENT>
<SENT sid="146" pm="."><plain>After temperature decreased to 30 °C, the sections were gradually rinsed with distilled H2O for five times. </plain></SENT>
<SENT sid="147" pm="."><plain>The sections were then blocked with 10% normal goat serum (NGS) for 30 min at RT, and incubated with primary antibodies in PBS containing 1% NGS overnight at 4 °C. </plain></SENT>
<SENT sid="148" pm="."><plain>After 3 washes with PBS, the sections were incubated in 10% NGS for 10min, and then with Alexa Fluor conjugated secondary antibody (Life Technologies, Grand Island, NY) (1:300) for 2 hours at RT in dark. </plain></SENT>
<SENT sid="149" pm="."><plain>Finally, the sections were rinsed three times with PBS, stained with DAPI, washed again with PBS for three times, and mounted with Fluoromount-G mounting medium (Southern Biotech, Birmingham, AL). </plain></SENT>
</text></p></sec><sec id="S12"><title><text><SENT sid="150" pm="."><plain>Expression vectors, recombinant proteins, peptides, antibodies and chemicals </plain></SENT>
</text></title><p id="P24"><text><SENT sid="151" pm="."><plain>MitoDsRed2 (Clontech, Mountain View, CA) and lentiviral packing plasmids (PCMV-dR8.2 and PCMV-VSVG from Addgene, Cambridge, MA) were obtained. </plain></SENT>
<SENT sid="152" pm="."><plain>Flag tagged TDP-43 constructs were generated by cloning TDP-43 into PCMV-3Tag-1a (Agilent, Santa Clara, CA) or pCMVTnT (Promega, Madison, WI). </plain></SENT>
<SENT sid="153" pm="."><plain>GFP fused with M1/3/5 constructs were generated based on PCMV-3Tag-9a (Agilent, Santa Clara, CA). </plain></SENT>
<SENT sid="154" pm="."><plain>TDP-43 mutations were all generated using QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent, Santa Clara, CA). </plain></SENT>
<SENT sid="155" pm="."><plain>MitoDsRed2/TDP-43 bicistronic lentiviral constructs were generated by cloning TDP-43 and mitoDsRed2 into pLVX-Puro (Clontech) and replacing PCMV promotor with mouse synapsin 1 promoter. </plain></SENT>
<SENT sid="156" pm="."><plain>ND3 or ND6 gene in nuclear format with the addition of mitochondrial targeting sequence from subunit VIII of human cytochrome c oxidase to the 5′-terminus (and the addition of myc tag to the 3′-terminus) were directly synthesized and subcloned into pcDNA3.1(+) (GenScript) (Table 2). </plain></SENT>
<SENT sid="157" pm="."><plain>Primers used for RT-PCR/Realtime-PCR (Life Technologies, Grand Island, NY) and RNAi oligonucleotides (Sigma St. Louis, MO; Tim22 esiRNAi: EHU160361-20UG and TIM23 esiRNAi: EHU106141-20UG) were obtained (Table 2). </plain></SENT>
<SENT sid="158" pm="."><plain>His tagged recombinant human TDP-43 was obtained from ATGEN (Gyeonggi-do, South Korea) and Flag tagged recombinant human TDP-43 were synthesized in rabbit reticulocyte system by coupled transcription/translation with biotin-lysyl-tRNA using pCMVTnT constructs (Promega, Madison, WI). </plain></SENT>
<SENT sid="159" pm="."><plain>cPM, PM1 and PM3 peptides (with/without FITC labeling) in which M1 or M3 motif or scrambled M1 or M3 motif fused to the C-terminus of the protein transduction domain (YGRKKRRQRRR) of the human immunodeficiency virus TAT protein to enhance peptide delivery/permeability as described23 were obtained from NeoBiolab (Woburn, MA) or Biomatik (Wilmington, DE). </plain></SENT>
<SENT sid="160" pm="."><plain>Primary antibodies used in this study are listed in Table 3. </plain></SENT>
<SENT sid="161" pm="."><plain>All chemicals were obtained (Sigma St. Louis, MO). </plain></SENT>
</text></p></sec><sec id="S13"><title><text><SENT sid="162" pm="."><plain>Embryonic primary cortical neuron, HEK293 cells and primary human fibroblasts culture and transfection </plain></SENT>
</text></title><p id="P25"><text><SENT sid="163" pm="."><plain>Primary cortical neurons were isolated from E18 Sprague Dawley rats (Harlan, Indianapolis, IN) as previously described52 with modifications. </plain></SENT>
<SENT sid="164" pm="."><plain>Taken briefly, rat brains were dissected out in HBSS (Life Technologies, Grand Island, NY) and stored in Hibernate E (BrainBits, Springfield, IL) supplemented with 2% B27 (Life Technologies, Grand Island, NY). </plain></SENT>
<SENT sid="165" pm="."><plain>Under a dissecting microscope, the meninges were removed completely with fine forceps and cortices were dissected out. </plain></SENT>
<SENT sid="166" pm="."><plain>Cortices were then digested in 0.25% trypsin for 15 min at room temperature (RT) followed by brief incubation in Opti-MEM (Life Technologies, Grand Island, NY) supplemented with 10% FBS and 50 units per ml DNAse I (Worthington-biochem, Lakewood Township, NJ). </plain></SENT>
<SENT sid="167" pm="."><plain>Digested cortices were further dissociated by gentle trituration with pipette until the cell suspension was homogenous and no large pieces of tissue remain visible. </plain></SENT>
<SENT sid="168" pm="."><plain>Cortical neurons were finally collected and seeded on poly-L-lysine/laminin coated coverslips/chamber slides (BD, Franklin Lakes, NJ), 35 mm dishes or 24 well plates and cultured as we described before46. </plain></SENT>
<SENT sid="169" pm="."><plain>HEK-293T cells from American Type Culture Collection (ATCC, Manassas, VA) were grown in DMEM medium (Life Technologies, Grand Island, NY), supplemented with 10% fetal bovine serum and 1% penicillin–streptomycin, in 5% CO2 in a humid incubator at 37 °C. </plain></SENT>
<SENT sid="170" pm="."><plain>Primary human fibroblasts from 4 age-matched normal subjects and 2 ALS patients bearing TDP-43 mutations (only 2 lines are available) were obtained from Coriell Institute for Medical Research (NINDS collection). </plain></SENT>
<SENT sid="171" pm="."><plain>Primary fibroblasts were grown in minimum essential medium (Life Technologies) containing non-essential amino acids and 2 mM glutamine, supplemented with 10% or 15% (v/v) fetal bovine serum, in 5% CO2 in a humid incubator at 37 °C as we described before53. </plain></SENT>
<SENT sid="172" pm="."><plain>HEK293 cells and primary human fibroblasts were tested free of mycoplasma contamination. </plain></SENT>
<SENT sid="173" pm="."><plain>Neurons were all transfected by NeuroMag (OZ Biosciences, San Diego, CA), while HEK293T cells and primary fibroblasts were transfected with lipofectamine 2000 (Life Technologies, Grand Island, NY) according to manufacturer’s protocol. </plain></SENT>
<SENT sid="174" pm="."><plain>For co-transfection, a 3:1 ratio (mitoDsRed2/TDP-43:GFP) was applied. </plain></SENT>
</text></p></sec><sec id="S14"><title><text><SENT sid="175" pm="."><plain>Generation of iPSCs using human fibroblasts and differentiation of iPSCs to human neurons </plain></SENT>
</text></title><p id="P26"><text><SENT sid="176" pm="."><plain>For reprogramming and differentiation, two lines of NHFs and TDP-43 G298S or A382T human fibroblasts were cultured in DMEM supplemented with 10% FBS (Life Technologies) and GlutaMAX (Life Technologies). </plain></SENT>
<SENT sid="177" pm="."><plain>Fibroblasts were reprogrammed using CytoTune-iPS 2.0 Sendai Reprogramming Kit (Life Technologies) according to manufacturer’s instruction using irradiated MEFs (iMEF) as feeder cells. </plain></SENT>
<SENT sid="178" pm="."><plain>iPSCs were routinely cultured on iMEFs in hESC medium (DMEM/F12 with GlutaMAX (Life Technologies), 10% KnockOut Serum Replacement (Life Technologies), 0.1 mM 2-mercaptoethanol (Life Technologies), 1 × non-essential amino acids (Life Technologies), and 10 ng/ml bFGF (Sigma). </plain></SENT>
<SENT sid="179" pm="."><plain>For differentiation, iPSCs were adapted and cultured in a feeder free conditions on matrigel in TeSR1 E8 medium (Stem Cell Technologies) and differentiated into induced neuronal progenitor cells (iNPCs) using StemDiff Neural Induction Medium and AggreWell 800 (both from Stem Cell Technologies) according to instructions. </plain></SENT>
<SENT sid="180" pm="."><plain>iNPCs were selected using Neural Rosette Selection Medium and further expanded using neural progenitor medium (both from Stem Cell Technologies). </plain></SENT>
<SENT sid="181" pm="."><plain>For characterization of iPSCs and iNPCs, immunofluorescence staining was carried out as previously described54 using antibodies against TRA-1-81, Nanog, SSEA3 and SSEA4. </plain></SENT>
<SENT sid="182" pm="."><plain>For alkaline phosphatase (AP) staining, Alkaline Phosphatase Staining Kit II (Stemgent) was used. </plain></SENT>
<SENT sid="183" pm="."><plain>iNPCs were differentiated into human neurons using Axol iNPCs differentiation and maturation kits (Axol, Cambridgeshire, United Kingdom) following manufacturer’s protocol. </plain></SENT>
<SENT sid="184" pm="."><plain>Taken briefly, iNPCs cells were first seeded on 24 or 48 well plates or 24 well seahorse plates coated with Axol SureBondXF in Axol Plating-XF medium. </plain></SENT>
<SENT sid="185" pm="."><plain>24 hours after plating, cells were transferred into neuronal differentiation medium (Axol Neuronal Differentiation-XF medium). </plain></SENT>
<SENT sid="186" pm="."><plain>After 72 hours, half of neuronal differentiation medium was replaced with neuronal maturation medium (Axol Neuronal Maintenance-XF medium) followed by half neuronal maturation medium change every four days. </plain></SENT>
<SENT sid="187" pm="."><plain>iPSCs and iNPCs used in the study were tested free of mycoplasma contamination. </plain></SENT>
<SENT sid="188" pm="."><plain>iPSCs derived neurons were also transfected by NeuroMag (OZ Biosciences, San Diego, CA). </plain></SENT>
</text></p></sec><sec id="S15"><title><text><SENT sid="189" pm="."><plain>Cellular and mitochondrial fractionation </plain></SENT>
</text></title><p id="P27"><text><SENT sid="190" pm="."><plain>Mitochondria were isolated as described before46. </plain></SENT>
<SENT sid="191" pm="."><plain>Taken briefly, cells were homogenized in IB-1 solution (IB-1: 225 mM mannitol, 75 mM sucrose, 0.1 mM EGTA, 20 mM HEPES; pH = 7.4), while tissues were homogenized in IB-1 with 0.5% BSA. </plain></SENT>
<SENT sid="192" pm="."><plain>The total homogenate (H) was centrifuged at 600 g for two times at 4 °C for 5 min. </plain></SENT>
<SENT sid="193" pm="."><plain>Subsequently, the supernatant (S1) was collected and centrifuged at 7,000 g at 4 °C for 10 min to obtain enriched mitochondrial fraction and the supernatant (S2) was collected. </plain></SENT>
<SENT sid="194" pm="."><plain>The enriched mitochondrial fraction was washed in IB-2 solution (225 mM mannitol, 75 mM sucrose, 20 mM HEPES; pH = 7.4) for cell mitochondria and IB-2 containing 0.5% BSA for tissue mitochondria followed by centrifugation at 9,000g for 10 min. </plain></SENT>
<SENT sid="195" pm="."><plain>The pellets were suspended in MRB buffer (250 mM Mannitol, 0.5 mM EGTA, 5 mM HEPES; pH 7.4) to obtain crude mitochondrial fraction (cM). </plain></SENT>
<SENT sid="196" pm="."><plain>The crude mitochondrial fraction was further overlaid on top of 8 ml Percoll medium (225 mM mannitol, 25 mM HEPES, 1 mM EGTA and 30% Percoll (vol/vol); pH = 7.4) and subjected to centrifugation at 95,000 g for 30 min at 4 °C in a SW40 Ti rotor. </plain></SENT>
<SENT sid="197" pm="."><plain>The pellet was suspended in MRB buffer again followed by centrifugation at 6,300 g for 10 min at 4 °C to obtained purified mitochondria (pM). </plain></SENT>
<SENT sid="198" pm="."><plain>Nuclear fraction was isolated/purified by nuclear extraction reagents (Thermo scientific, Waltham, MA). </plain></SENT>
</text></p><p id="P28"><text><SENT sid="199" pm="."><plain>For sub-mitochondrial compartment fractionation, isolated pure mitochondria were suspended in isolation medium (225 mM mannitol, 75 mM sucrose, 0.1 mM EGTA, 20 mM HEPES; pH = 7.4) with digitonin at 0.12 mg digitonin/mg mitochondria and stirring gently on ice for 15 min. </plain></SENT>
<SENT sid="200" pm="."><plain>Then digitonin treated samples were diluted with 3 volume of isolation medium and centrifuged at 9,000 g for 10 min to get supernatant A followed by pellet resuspension in isolation buffer and sonicated for 30 seconds on ice. </plain></SENT>
<SENT sid="201" pm="."><plain>Then the solution was sonicated and centrifuged at 6,500 g for 10 min followed by centrifugation at 144,000 g for 60 min to sediment the inner membrane vesicles and the supernatant was collected as matrix fraction. </plain></SENT>
<SENT sid="202" pm="."><plain>Supernatant A was centrifuged at 144,000 g for 60 min to sediment outer membrane vesicles as pellets and the supernatant was collected as inner membrane space fraction. </plain></SENT>
</text></p></sec><sec id="S16"><title><text><SENT sid="203" pm="."><plain>Synaptosome isolation </plain></SENT>
</text></title><p id="P29"><text><SENT sid="204" pm="."><plain>Synaptosomes were isolated from mouse cortices or spinal cords as described55. </plain></SENT>
<SENT sid="205" pm="."><plain>Taken briefly, fresh cortex tissue was homogenized in ice cold ‘Sucrose Medium’ (320 mM sucrose, 1 mM EDTA, 0.25 mM dithiothreitol, pH = 7.4 followed by centrifugation at 1,000 g for 10 min at 4 °C. </plain></SENT>
<SENT sid="206" pm="."><plain>The supernatant was collected and carefully layered on top of a discontinuous Percoll gradient (3 ml layers of 3, 10, and 23% Percoll in sucrose medium) in a 15 mL centrifuge tube followed by centrifugation at 32,500 g for 10 min at 4 °C in a SW-40Ti rotor. </plain></SENT>
<SENT sid="207" pm="."><plain>The band between 10% and 23% Percoll was collected and diluted into ionic medium (20 mM HEPES, 10 mM D-glucose, 1.2 mM Na2HPO4, 1 mM MgCl2, 5 mM NaHCO3, 5 mM KCl, 140 mM NaCl, pH = 7.4) followed by centrifugation at 15,000 g for 15 min at 4 °C to remove Percoll. </plain></SENT>
<SENT sid="208" pm="."><plain>The pellets, i.e. synaptosome fractions, were collected and resuspended in ionic media again and seeded on polyethyleneimine coated plates by centrifugation at 3,000 g at 4 °C for 30 min. </plain></SENT>
<SENT sid="209" pm="."><plain>The purity of synaptosome was confirmed by immunoblot of synaptic makers or EM (data not shown). </plain></SENT>
</text></p></sec><sec id="S17"><title><text><SENT sid="210" pm="."><plain>Mitochondrial function and cell viability measurement </plain></SENT>
</text></title><p id="P30"><text><SENT sid="211" pm="."><plain>The mΔψ in HEK293 cells, human fibroblasts, primary neurons or synaptic mitochondria was determined by tetramethylrhodamine (TMRM) and/or rhodamine 123 (rhod123) as we described before56. </plain></SENT>
<SENT sid="212" pm="."><plain>Taken briefly, HEK293 cells, human fibroblasts, primary neurons cultured in in 35mm dishes or 24 well plates, or isolated synaptosomes attached to 24 well plates pre-coated with polyethyleneimine as described55 (1:15000 dilution from a 50% solution, Sigma) were incubated with 20 nM TMRM or 2 μM rhod123 in PBS (Phosphate-Buffered Saline pH 7.4, Life Technologies, Grand Island, NY; for HEK293 cells and human fibroblasts), HEPES-buffered Tyrode’s solution (119 mM NaCl, 5 mM KCl, 6 g/liter D-glucose, 2 mM CaCl2, 2 mM MgCl2, and 25 mM HEPES; pH = 7.4; for primary neurons) or ionic medium (for synaptic mitochondria) for 30 min. </plain></SENT>
<SENT sid="213" pm="."><plain>The TMRM/rhod123 containing solution was removed. </plain></SENT>
<SENT sid="214" pm="."><plain>After three times wash with PBS, Tyrode’s or ionic medium, cells/neurons/synaptosome were incubated in PBS or Tyrode’s solution at 37 °C in room air for 10 min to allow the stead of TMRM/rhod123 signal before imaging by fluorescence microscope. </plain></SENT>
<SENT sid="215" pm="."><plain>ATP levels were measured by the ATP Colorimetric/Fluorometric Assay Kit (Biovision, Milpitas, CA) using cell or neuronal lysate as described before56. </plain></SENT>
<SENT sid="216" pm="."><plain>The real-time measurement of oxygen consumption rate (OCR) in live cultured HEK293 cells, human fibroblasts and neurons with optimal seeding density as indicated or synaptic mitochondria in synaptosomes was performed using the Seahorse XF24 Analyzer (Seahorse Bioscience, North Billerica, MA) according to the user’s instruction. </plain></SENT>
<SENT sid="217" pm="."><plain>If needed, ATP synthase inhibitor oligomycin (1 μM), uncoupler FCCP (4 μM) and complex I inhibitors antimycin A (1 μM) and rotenone (1 μM) were injected sequentially. </plain></SENT>
<SENT sid="218" pm="."><plain>After measurement, cells and synaptosomes were lysed and OCR data was normalized by total protein. </plain></SENT>
<SENT sid="219" pm="."><plain>Cell death and viability was measured by Cytotoxicity Detection Kit (LDH; Roche, Nutley, NJ), immunofluorescent staining using a specific antibody against cleaved caspase 3 staining or SYTOX green assay (Life Technologies, Grand Island, NY). </plain></SENT>
<SENT sid="220" pm="."><plain>For SYTOX green dead neuron staining, neurons were incubated in PBS containing 30 nM SYTOX green for 20 minutes at room temperature followed by three times wash with PBS. </plain></SENT>
<SENT sid="221" pm="."><plain>Neurons with SYTOX green-positive nuclei and/or obvious fragmented nuclear/neurites were counted as non-viable neurons, whereas neurons without SYTOX green-positive nuclei and clear nuclear contour/neurites were counted as viable neurons. </plain></SENT>
</text></p></sec><sec id="S18"><title><text><SENT sid="222" pm="."><plain>Mitochondria import assay </plain></SENT>
</text></title><p id="P31"><text><SENT sid="223" pm="."><plain>Mitochondria were isolated from mouse brain, while mitoplasts were prepared by incubating isolated mitochondria with digitonin (0.1 mg per 1 mg of mitochondrial protein) on ice for 15 min followed by centrifugation at 11,000 g for 10 min. </plain></SENT>
<SENT sid="224" pm="."><plain>The import buffer used was composed of 250 mM sucrose, 10 mM MOPS-KOH, pH 7.2, 80 mM KCl, 5 mM MgCl2, 2 mM ATP, 2 mM NADH, 3% BSA. </plain></SENT>
<SENT sid="225" pm="."><plain>The import assays were carried out by incubating mitochondria or mitoplasts with indicated recombinant proteins at RT for 45 min. </plain></SENT>
<SENT sid="226" pm="."><plain>The import reactions were stopped by adding valinomycin (1 μM). </plain></SENT>
<SENT sid="227" pm="."><plain>Equal volume of import reactions were treated by 0.25% trypsin or 0.25% trypsin and digitonin (5 mg per 10 mg mitochondria) as needed at RT for 5 min followed by centrifugation at 11,000 g for 10 min. </plain></SENT>
<SENT sid="228" pm="."><plain>At last, the mitochondria or mitoplasts pellets were resuspended in cell lysis buffer (Cell signaling, Danvers, MA) supplemented with protease inhibitor cocktail (Roche, Nutley, NJ) and phenylmethylsulfonyl fluoride (PMSF, Sigma, St. Louis, MO). </plain></SENT>
<SENT sid="229" pm="."><plain>Mitochondrial proteins need to be unfolded during import22, suggesting the existence of chaperones in reticulocyte lysates facilitating rTDP-43 import in vitro. </plain></SENT>
<SENT sid="230" pm="."><plain>Although rTDP-43 import could be increased by urea-denaturation (data not shown), recombinant proteins generated in reticulocyte lysates also demonstrated efficient import in vitro. </plain></SENT>
<SENT sid="231" pm="."><plain>Therefore, in this study, we used recombinant proteins without denaturation. </plain></SENT>
</text></p></sec><sec id="S19"><title><text><SENT sid="232" pm="."><plain>Measurements of activities of respiratory chain complex I to V </plain></SENT>
</text></title><p id="P32"><text><SENT sid="233" pm="."><plain>Enzyme activity of complex I-IV was measured as described57. </plain></SENT>
<SENT sid="234" pm="."><plain>Taken briefly, after three cycles of freeze and thaw, isolated mitochondria were resuspended in a total volume of 200 μl reaction buffer. </plain></SENT>
<SENT sid="235" pm="."><plain>Complex I (NADH:ubiquinone oxidoreductase) activity was measured in reaction buffer containing 25mM potassium phosphate, 5 mM MgCl2, 2.5 mg/ml of BSA, 0.13 mM NADH, 2 μg/ml antimycin A, and 65 μM ubiquinone1 at 340 nm for 5 min before and after the addition of rotenone (2 μg/ml). </plain></SENT>
<SENT sid="236" pm="."><plain>Complex II (succinate: ubiquinone oxidoreductase) activity was measured in reaction buffer containing 25 mM potassium phosphate, 2.5 mg/ml of BSA, 20 mM sodium succinate, 0.05 mM DCPIP, 2 mM KCN, and 65 μM ubiquinone1 at 600 nm. </plain></SENT>
<SENT sid="237" pm="."><plain>The reaction was started through the addition of 65 μM ubiquinone1. </plain></SENT>
<SENT sid="238" pm="."><plain>Complex III (ubiquinol2:cytochrome c reductase) activity was measured in reaction buffer containing 25 mM potassium phosphate, 2.5 mg/ml of BSA, 2 mM KCN, 2 μg/ml rotenone, 0.6 mM n-dodecyl-b-D-maltoside, 15 μM cytochrome c and 35 μM ubiquinol2 at 550 nm. </plain></SENT>
<SENT sid="239" pm="."><plain>Complex IV (cytochrome c oxidase) activity was measured in reaction buffer containing 25 mM potassium phosphate, 0.45 mM n-dodecyl-b-D-maltoside and 15 μM cytochrome c. Complex IV activity at 550 nm. </plain></SENT>
<SENT sid="241" pm="."><plain>Complex V (F1-ATP synthase) activity was determined in assay buffer containing 40 mM Tris-HCO3, 10 mM EGTA pH8.0, 0.2 mM NADH, 2.5 mM PEP, 25 μg/ml antimycin A, 0.5 mg/ml LDH, 0.5 mg/ml PK and 2.5 mM ATP. </plain></SENT>
<SENT sid="242" pm="."><plain>Complex V activity was measured following the change in absorbance at 340 nm due to NADH oxidation. </plain></SENT>
</text></p></sec><sec id="S20"><title><text><SENT sid="243" pm="."><plain>RNA immunoprecipitation and RT-PCR/Real time PCR </plain></SENT>
</text></title><p id="P33"><text><SENT sid="244" pm="."><plain>Isolated mitochondria were first lysed by immunoprecipitation lysis buffer (50 mM Tris, pH 7.4, 250 mM NaCl, 5 mM EDTA, 50 mM NaF, 1 mM Na3VO4, 1% Nonidet P40 (NP40) and 0.02% NaN3) containing 1X protease inhibitor cocktail (Cell signaling, Danvers, MA) and 100U/ml Ribonuclease Inhibitor (Life Technologies, Grand Island, NY). </plain></SENT>
<SENT sid="245" pm="."><plain>The homogenate was then centrifuged at 18,000 g at 4 °C for 30 min. </plain></SENT>
<SENT sid="246" pm="."><plain>The supernatant was collected and incubated with magnetic beads bound by TDP43 antibody overnight at 4 °C. </plain></SENT>
<SENT sid="247" pm="."><plain>Magnetic beads were then washed with lysis buffer and RNAs were extracted by TRIzol reagent (Life Technologies, Grand Island, NY). </plain></SENT>
<SENT sid="248" pm="."><plain>Total RNAs from HEK-293T cells and human spinal cord tissues were also extracted by TRIzol reagent (Life Technologies, Grand Island, NY). </plain></SENT>
<SENT sid="249" pm="."><plain>mtDNA was removed by DNase I treatment and was verified by PCR. </plain></SENT>
<SENT sid="250" pm="."><plain>Reverse transcriptions were performed by High Capacity cDNA Reverse Transcription Kit with random oligomer primers (Life Technologies, Grand Island, NY). </plain></SENT>
<SENT sid="251" pm="."><plain>qRT-PCR analysis of all mitochondria transcripts were performed on StepOnePlus system with appropriate primer pairs using SYBR Green master mix (Life Technologies, Grand Island, NY). </plain></SENT>
<SENT sid="252" pm="."><plain>See table 1 for primers used (A8/ND4L have not been specifically measured and amplified due to their short sequences). </plain></SENT>
</text></p></sec><sec id="S21"><title><text><SENT sid="253" pm="."><plain>Mitochondrial nascent protein synthesis in HEK293 cells </plain></SENT>
</text></title><p id="P34"><text><SENT sid="254" pm="."><plain>HEK293 cells expressing Flag tagged TDP-43 were cultured in DMEM culture medium without methionine (Life Technologies, Grand Island, NY) for 1 hour followed by pretreatment with 0.1mg/ml emetine for 10 min and co-treatment with 0.1mg/ml emetine and L-Azidohomoalanine (AHA, Life Technologies, Grand Island, NY) for 4 hours. </plain></SENT>
<SENT sid="255" pm="."><plain>After pulse labelling, cells were harvested followed by mitochondrial fractionation. </plain></SENT>
<SENT sid="256" pm="."><plain>Isolated mitochondria were lysed with 1% SDS in 50 mM Tris-HCl, pH 8.0 followed by centrifugation at 10,000 g for 10 min. </plain></SENT>
<SENT sid="257" pm="."><plain>The supernatant was incubated with avidin- dynabeads (Life Technologies, Grand Island, NY) at RT for 30 min. </plain></SENT>
<SENT sid="258" pm="."><plain>After the removal of beads, the supernatant was subjected to Click-it assay (Life Technologies, Grand Island, NY). </plain></SENT>
<SENT sid="259" pm="."><plain>Taken briefly, 200 μg mitochondria proteins were labeled with PEG4-carboxamide-6-Azidohexanyl-biotin in a 160 μl volume system, and total proteins were precipitated and extracted by methanol and chloroform. </plain></SENT>
<SENT sid="260" pm="."><plain>After centrifugation at 18,000 g for 5 min, the total protein pellets were collected and dissolved by 1% SDS in 50mM Tris-HCl for western blot. </plain></SENT>
</text></p></sec><sec id="S22"><title><text><SENT sid="261" pm="."><plain>Fractionation for mitochondrial ribosomes and their loading on RNAs </plain></SENT>
</text></title><p id="P35"><text><SENT sid="262" pm="."><plain>Isolated mitochondria were lysed in lysis buffer (260 mM sucrose, 100 mM KCl, 20 mM MgCl2, 10 mM Tris-Cl pH 7.5, 1% Triton X-100, 5 mM β-mercaptoethanol and protease inhibitor) on ice for 20 min. </plain></SENT>
<SENT sid="263" pm="."><plain>Lysates were centrifuged at 9,400 g for 30 min at 4 °C. </plain></SENT>
<SENT sid="264" pm="."><plain>Then supernatants were loaded on 11 ml 10%–30% continuous linear sucrose gradient (50 mM Tris-Cl, 100 mM KCl, 10 mM MgCl2) and centrifuged at 20,400 rpm for 15 hours in a Beckman SW41-Ti rotor at 4 °C. </plain></SENT>
<SENT sid="265" pm="."><plain>After centrifugation, 13 fractions were collected from the top and used for further immunoblot and qRT-PCR analysis. </plain></SENT>
</text></p></sec><sec id="S23"><title><text><SENT sid="266" pm="."><plain>Blue native PAGE and immunoblot analysis </plain></SENT>
</text></title><p id="P36"><text><SENT sid="267" pm="."><plain>Blue native gel electrophoresis was performed with NativePAGE Bis-Tris Gel system (Life Technologies, Grand Island, NY). </plain></SENT>
<SENT sid="268" pm="."><plain>Briefly, isolated mitochondria containing 10 μg of mitochondrial proteins were resuspended in sample buffer and solubilized with 2% digitonin (Sigma) for 30 min on ice. </plain></SENT>
<SENT sid="269" pm="."><plain>Insolubilized pellets were removed by centrifugation for 30 min at 18,000 g. The supernatant was collected and 5% G-250 sample additive was added. </plain></SENT>
<SENT sid="271" pm="."><plain>Samples were loaded to 3–12% precast Bis-Tris gradient gels (Life Technologies, Grand Island, NY) followed by electrophoresis at a voltage of 40 V with light blue running buffers at 4 °C. </plain></SENT>
<SENT sid="272" pm="."><plain>For regular immunoblot analysis, purified mitochondria, cells or tissues were lysed with cell lysis buffer (Cell signaling, Danvers, MA) plus 1 mM PMSF and protease inhibitor cocktail (Roche, Nutley, NJ). </plain></SENT>
<SENT sid="273" pm="."><plain>Equal amounts of 10 μg total protein extract were resolved by SDS-PAGE and transferred to Immobilon-P (Millipore, Billerica, MA). </plain></SENT>
<SENT sid="274" pm="."><plain>Following blocking with 10% nonfat dry milk, primary and secondary antibodies were applied as previously described56 and the blots were developed with Immobilon Western Chemiluminescent HRP Substrate (Millipore, Billerica, MA). </plain></SENT>
<SENT sid="275" pm="."><plain>Frozen human thoracic spinal cord tissues from 6 age-matched normal and 8 patients with sALS were obtained from NICHD Brain and Tissue Bank (Table 1). </plain></SENT>
</text></p></sec><sec id="S24"><title><text><SENT sid="276" pm="."><plain>RNA-protein in vitro binding assay </plain></SENT>
</text></title><p id="P37"><text><SENT sid="277" pm="."><plain>ND3 RNA probe (5′-UCCACCCCUUACGAGUGCGGCUUCGACCCUAUAUC-3′) and mutant ND3 RNA probe (5′-UCCACCCCUUACAAAUAAAGCUUCGACCCUAUAUC-3′) were purchased from GenScript (Piscataway, NJ). </plain></SENT>
<SENT sid="278" pm="."><plain>RNA-protein binding was performed in 20 μl reactions containing 1μM RNA probe. </plain></SENT>
<SENT sid="279" pm="."><plain>The binding conditions were 10 mM Tris at pH 7.5, 10 mM HEPES at pH 7.5, 20 mM KCl, 2 mM MgCl2, 1.5 mM DTT, 5% glycerol. </plain></SENT>
<SENT sid="280" pm="."><plain>After incubation at RT for 30 min, samples were run at 100 V on a pre-electrophoresed 6% polyacrylamide gel containing 0.5×TBE for 1 hour in ice water bath. </plain></SENT>
<SENT sid="281" pm="."><plain>Gel was stained by SYBR Green solution (Life Technologies, Grand Island, NY) for 20 min at RT. </plain></SENT>
<SENT sid="282" pm="."><plain>Then stained gel was rinsed with water for three times and visualized by EpiChemi II Darkroom (UVP, Upland, CA) </plain></SENT>
</text></p></sec><sec id="S25"><title><text><SENT sid="283" pm="."><plain>Lentivirus production, stereotaxic injection and cryosection </plain></SENT>
</text></title><p id="P38"><text><SENT sid="284" pm="."><plain>Lenti-X 293T cells (Clontech, Mountain View, CA) were transfected with bicistronic lentiviral construct and two helper plasmids: PCMV-dR8.2 and PCMV-VSVG at 6 μg, 4.5 μg, and 1.5 μg of DNA per 10 cm plate using PerFectin (Genlantis, San Diego, CA). </plain></SENT>
<SENT sid="285" pm="."><plain>48 h after transfection, culture medium was centrifuged at 780 g for 30 min and filtered at a 0.45μm pore size. </plain></SENT>
<SENT sid="286" pm="."><plain>Filtered medium was further laid on the top of 20% sucrose followed by centrifugation in Beckman SW-28 rotor at 90,000 g for 2 hours. </plain></SENT>
<SENT sid="287" pm="."><plain>The pellet was collected and resuspended in PBS or saline. </plain></SENT>
<SENT sid="288" pm="."><plain>Procedures for lentiviral injections into mice were performed according to the NIH guidelines and were approved by the Institutional Animal Care and Use Committee (IACUC) at Case Western Reserve University. </plain></SENT>
<SENT sid="289" pm="."><plain>For virus injection, mice were anesthetized using avertin (250 mg/kg) and placed in a stereotactic frame. </plain></SENT>
<SENT sid="290" pm="."><plain>A small incision was made to expose the skull surface. </plain></SENT>
<SENT sid="291" pm="."><plain>Holes were drilled in the skull overlying the motor cortex region (AP/Anterior-Posterior: 1 mm; ML/Medial-Lateral: 1 mm). </plain></SENT>
<SENT sid="292" pm="."><plain>The needle filled with virus was lowered down 0.7 mm (DV/Dorsal-Ventral) and 2 μl virus (109 viral particles/ml) was injected in 5 min. </plain></SENT>
<SENT sid="293" pm="."><plain>The needle was left in place 5 min before slow withdraw. </plain></SENT>
<SENT sid="294" pm="."><plain>Skin was sutured and mice were allowed to recover on warm pads. </plain></SENT>
<SENT sid="295" pm="."><plain>One week after injection, mice were deeply anesthetized with avertin and transcardially perfused with cold PBS. </plain></SENT>
<SENT sid="296" pm="."><plain>The brain was fixed in paraformaldehyde (4%) for 24 hours and then in 30% sucrose for 24 hours again. </plain></SENT>
<SENT sid="297" pm="."><plain>After cryoprotection, the brain coronal sections were cut at 20 μm thickness for immunostaining. </plain></SENT>
<SENT sid="298" pm="."><plain>3 months old C57BL/6 mice, male or female, were randomly assigned to receiving different injections. </plain></SENT>
<SENT sid="299" pm="."><plain>The outcomes were independently assessed by an investigator without knowledge of injections. </plain></SENT>
</text></p></sec><sec id="S26"><title><text><SENT sid="300" pm="."><plain>In vivo administration of TAT-peptide </plain></SENT>
</text></title><p id="P39"><text><SENT sid="301" pm="."><plain>Mice surgery/procedures were performed according to the NIH guidelines and were approved by the Institutional Animal Care and Use Committee (IACUC) at Case Western Reserve University. </plain></SENT>
<SENT sid="302" pm="."><plain>Minimal number of mice were used (at least 3/group). </plain></SENT>
<SENT sid="303" pm="."><plain>C57BL/6 non-transgenic wild type mice (NTG mice), Prnp-TARDBP mice (TDP-43 WT Tg mice) and Prnp-TARDBP*A315T mice (TDP-43 A315T Tg mice) were purchased from the Jackson Laboratory (Bar Harbor, ME). </plain></SENT>
<SENT sid="304" pm="."><plain>2–3 months old male or female mice were randomly assigned to receiving treatment. </plain></SENT>
<SENT sid="305" pm="."><plain>Mice were infused subcutaneously with mini-osmotic pumps (Alzet Model 2004, Cupertino, CA; flow rate of 0.25 μl/hour for 10 days). </plain></SENT>
<SENT sid="306" pm="."><plain>One day before implantation, mini-osmotic pumps were filled with 200 μl PBS containing cPM or PM1 peptides (0.5 mg/kg/day) followed by pump incubation in PBS at 37 °C overnight according to the manufacturer’s instructions. </plain></SENT>
<SENT sid="307" pm="."><plain>For surgery, male mice were anesthetized with avertin. </plain></SENT>
<SENT sid="308" pm="."><plain>A small incision was made at the back of mouse and mini-osmotic pump were implanted subcutaneously. </plain></SENT>
<SENT sid="309" pm="."><plain>After treatment, mice were deeply anesthetized with avertin and transcardially perfused with cold PBS and spinal cord and brain tissues were collected followed by fractionation, western blot or immunostaining. </plain></SENT>
<SENT sid="310" pm="."><plain>The outcomes were independently assessed by an investigator without knowledge of treatments. </plain></SENT>
</text></p></sec><sec id="S27"><title><text><SENT sid="311" pm="."><plain>Motor behavioral assessment </plain></SENT>
</text></title><p id="P40"><text><SENT sid="312" pm="."><plain>The Rotarod test was used to assay motor coordination and balance of mice using Panlab Rota-Rods (Harvard Apparatus, Holliston, MA) as described58. </plain></SENT>
<SENT sid="313" pm="."><plain>Taken briefly, mice first received training with 3 trials a day for 3 days (4–12 rpm for less than 3 minutes with at least 10 minute intervals between trials). </plain></SENT>
<SENT sid="314" pm="."><plain>All mice used in this study reached a stable Rotarod performance after training (data not shown). </plain></SENT>
<SENT sid="315" pm="."><plain>Three days after training, mice were assayed at the accelerating mode (4 – 40 rpm over 5 minutes) for three times every week. </plain></SENT>
<SENT sid="316" pm="."><plain>All Rotarod tests were performed with at least 5 minutes intervals for different genotypes and interspersed to avoid habituation. </plain></SENT>
<SENT sid="317" pm="."><plain>Footprint analyses were performed using a customized runway (50 cm long, 5 cm wide and both sides bordered). </plain></SENT>
<SENT sid="318" pm="."><plain>The forepaw and hindpaw of mice were first dipped into red and blue non-toxic paints. </plain></SENT>
<SENT sid="319" pm="."><plain>Subsequently, mice were placed on the runway covered by white paper and ran into an enclosed dark box. </plain></SENT>
<SENT sid="320" pm="."><plain>Footprints of sitting mice were not included in quantification. </plain></SENT>
<SENT sid="321" pm="."><plain>Stride length is the mean distance of forward movement between each stride, while base length is the mean distance between left and right forepaw or hindpaw. </plain></SENT>
</text></p></sec><sec id="S28"><title><text><SENT sid="322" pm="."><plain>Confocal microscopy, fluorescent microscopy and electron microscopy </plain></SENT>
</text></title><p id="P41"><text><SENT sid="323" pm="."><plain>All confocal images were captured at RT with a Zeiss LSM 510 inverted laser-scanning confocal fluorescence microscope (controlled through Zeiss LSM 510 confocal software, Zeiss) equipped with a C-Apochromat 40×/1.2W water objective or alpha Plan-Fluar 100×/1.45 oil objective as previously described56. </plain></SENT>
<SENT sid="324" pm="."><plain>Confocal images of far-red fluorescence were collected using 633 nm excitation light from a HeNe laser and a 650 nm long-pass filter; images of red fluorescence were collected using 543 nm excitation light from an argon laser and a 560 nm long-pass filter; and green fluorescence images were collected using 488 nm excitation light from an argon laser and a 500–550 nm bandpass barrier filter. </plain></SENT>
</text></p><p id="P42"><text><SENT sid="325" pm="."><plain>For time-lapse imaging or regular fluorescence imaging of TMRM, Rhod123 and SYTOX green, cells or neurons were seeded in 35 mm dishes or 24 well plates, and infected/transfected with mito-DsRed2 or indicated plasmids. </plain></SENT>
<SENT sid="326" pm="."><plain>Cells or neurons were imaged by an inverted Leica DMI6000 fluorescence microscope (Leica) (controlled through Leica LAS AF 3 software) with a 20X/0.7NA Plan Apochromat dry objective and well-equipped with environmental chamber with controlled CO2 content, humidity and temperature (37 °C). </plain></SENT>
<SENT sid="327" pm="."><plain>Images were captured with lowest intensity to avoid photobleaching or signal oversaturation. </plain></SENT>
<SENT sid="328" pm="."><plain>During time-lapse imaging, frames were captured every 10 s for at least 1 h without phototoxicity or photobleaching. </plain></SENT>
</text></p><p id="P43"><text><SENT sid="329" pm="."><plain>For immuno-EM, biopsied human brain tissue, cells and isolated mitochondria were fixed in 4% w/v formaldehyde containing 0.1% w/v glutaraldehyde in 0.1 M HEPES buffer (Electron Microscopy Sciences, Hatfield, PA) at RT for 45 min, then dehydrated in ethanol and embedded in LR White resin (Polysciences, Inc., Warrington, PA). </plain></SENT>
<SENT sid="330" pm="."><plain>Immuno-gold labeling procedure was performed according to the method described by Fujioka et al.59. </plain></SENT>
<SENT sid="331" pm="."><plain>Thin sections were blocked with PBS containing 1% w/v bovine serum albumin (BSA), 1% v/v normal goat serum and 0.01% v/v Tween 20 (PBGT). </plain></SENT>
<SENT sid="332" pm="."><plain>Grids were then incubated with antibodies (anti-Flag or anit-TDP-43) at 1:10–1:30 dilution in PBGT for 12 hours at 4 °C. </plain></SENT>
<SENT sid="333" pm="."><plain>Negative controls included normal rabbit serum, normal mouse serum, and PBT replaced as the primary antibody. </plain></SENT>
<SENT sid="334" pm="."><plain>After washing, grids were incubated for 1.5 hour in 10nm gold-conjugated goat anti-rabbit IgG or goat anti-mouse IgG (British BioCell International, Ted Pella, Inc., Redding, CA) diluted 1:20 in PBGT, rinsed with PBS, and fixed with glutaraldehyde to stabilize the gold particles59. </plain></SENT>
<SENT sid="335" pm="."><plain>Gold-labelled thin sections were stained first with 2% acidified uranyl acetate at 38 °C for 30 min, then with the triple lead stain of Sato as modified by Hanaichi et al60, then examined in an FEI Tecnai Spirit (T12) with a Gatan US4000 4k×4k CCD. </plain></SENT>
<SENT sid="336" pm="."><plain>For regular EM, samples were freshly dissected and processed for transmission electron microscopy as previously described61: Small pieces of the tissue or isolated mitochondria were fixed by immersion in triple aldehyde-DMSO. </plain></SENT>
<SENT sid="337" pm="."><plain>After rinsing in distilled water, they were postfixed in ferrocyanide-reduced osmium tetroxide. </plain></SENT>
<SENT sid="338" pm="."><plain>Another water rinse was followed by an overnight soak in acidified uranyl acetate. </plain></SENT>
<SENT sid="339" pm="."><plain>After again rinsing in distilled water, the tissue blocks were dehydrated in ascending concentrations of ethanol, passed through propylene oxide, and embedded in Poly/Bed resin. </plain></SENT>
<SENT sid="340" pm="."><plain>Thin sections were sequentially stained with acidified uranyl acetate followed by a modification of Sato’s triple lead stain and examined in an examined in an FEI Tecnai Spirit (T12) with a Gatan US4000 4kx4k CCD. </plain></SENT>
</text></p></sec><sec id="S29"><title><text><SENT sid="341" pm="."><plain>Image analysis </plain></SENT>
</text></title><p id="P44"><text><SENT sid="342" pm="."><plain>Image analysis was also performed with open-source image analysis programs WCIF ImageJ (developed by W. Rasband). </plain></SENT>
<SENT sid="344" pm="."><plain>3D images were reconstructed using “3D Viewer” plugin and continuous images with 200 nm optical thickness. </plain></SENT>
<SENT sid="345" pm="."><plain>Line scan analysis were performed using “RGB Profiler Plot” plugin. </plain></SENT>
<SENT sid="346" pm="."><plain>Taken briefly, raw confocal images were background corrected. </plain></SENT>
<SENT sid="347" pm="."><plain>A straight line with “2” width was drawn in regions of interest. </plain></SENT>
<SENT sid="348" pm="."><plain>Then the lines were directly analyzed by choosing ImageJ plugin Graphics’s “RGB Profiler Plot” under the “Plugins” menu. </plain></SENT>
<SENT sid="349" pm="."><plain>In the output of “RGB Profiler”, data was exported into Microsoft Excel. </plain></SENT>
<SENT sid="350" pm="."><plain>The length of line was plotted on the x-axis, while the intensity was plotted on the y-axis. </plain></SENT>
<SENT sid="351" pm="."><plain>Kymograph and quantification of mitochondrial movement were performed using “MultipleKymograph” as described (<ext-link ext-link-type="uri" xlink:href="http://www.embl.de/eamnet/html/body_kymograph.html">http://www.embl.de/eamnet/html/body_kymograph.html</ext-link>). </plain></SENT>
<SENT sid="352" pm="."><plain>Mitochondria morphology in fibroblasts and HEK293 cells was quantified as we described62. </plain></SENT>
<SENT sid="353" pm="."><plain>Taken briefly, single plane or series of z-stacks of raw images were background corrected, linearly contrast optimized, applied with a 7 × 7 ‘top hat’ filter, subjected to a 3 × 3 median filter and then thresholded to generate binary images. </plain></SENT>
<SENT sid="354" pm="."><plain>Most mitochondria were well separated in binary images and large clusters of mitochondria were excluded automatically. </plain></SENT>
<SENT sid="355" pm="."><plain>All binary images were further analyzed by Image J. Mitochondrial morphology in neurons or EM micrographs were all directly analyzed by image J. </plain></SENT>
</text></p></sec><sec id="S30"><title><text><SENT sid="357" pm="."><plain>Data collection and statistical analysis </plain></SENT>
</text></title><p id="P45"><text><SENT sid="358" pm="."><plain>Our power analysis indicated that to detect 20% difference at α=0.05 and β=0.8, with &lt; 0.05 probability of false errors using the typical variances we have in our data requires a minimum of 12 samples. </plain></SENT>
<SENT sid="359" pm="."><plain>No samples were excluded in this study. </plain></SENT>
<SENT sid="360" pm="."><plain>All the outcomes were independently assessed by investigator without knowledge of treatments. </plain></SENT>
<SENT sid="361" pm="."><plain>Statistical analysis was done with one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparison test or student-t-test. </plain></SENT>
<SENT sid="362" pm="."><plain>Data are means ± s.e.m. n represents number of neurons, cells or mice per experiment. p&lt;0.05 was considered to be statistically significant. n.s., not significant. </plain></SENT>
<SENT sid="363" pm="."><plain>Data were normally distributed with similar variance between the groups. </plain></SENT>
<SENT sid="364" pm="."><plain>All statistical analyses were performed in a blinded fashion. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="SUPPL"><sec sec-type="supplementary-material" id="S31"><title><text><SENT sid="365" pm="."><plain>Supplementary Material </plain></SENT>
</text></title><supplementary-material content-type="local-data" id="SD1"><label>supp_SuppFigs,Tables1-3,movielegends</label><media xlink:href="NIHMS789731-supplement-supp_SuppFigs_Tables1-3_movielegends.pdf" orientation="portrait" xlink:type="simple" id="d37e1047" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>supp_sourcedatafig1</label><media xlink:href="NIHMS789731-supplement-supp_sourcedatafig1.xlsx" orientation="portrait" xlink:type="simple" id="d37e1051" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD3"><label>supp_sourcedatafig2</label><media xlink:href="NIHMS789731-supplement-supp_sourcedatafig2.xlsx" orientation="portrait" xlink:type="simple" id="d37e1055" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD4"><label>supp_sourcedatafig3</label><media xlink:href="NIHMS789731-supplement-supp_sourcedatafig3.xlsx" orientation="portrait" xlink:type="simple" id="d37e1059" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD5"><label>supp_sourcedatafig4</label><media xlink:href="NIHMS789731-supplement-supp_sourcedatafig4.xlsx" orientation="portrait" xlink:type="simple" id="d37e1063" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD6"><label>supp_sourcedatafig5</label><media xlink:href="NIHMS789731-supplement-supp_sourcedatafig5.xlsx" orientation="portrait" xlink:type="simple" id="d37e1067" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD7"><label>supp_sourcedatafig6</label><media xlink:href="NIHMS789731-supplement-supp_sourcedatafig6.xlsx" orientation="portrait" xlink:type="simple" id="d37e1071" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD8"><label>video1</label><media xlink:href="NIHMS789731-supplement-video1.avi" orientation="portrait" xlink:type="simple" id="d37e1075" position="anchor" mimetype="video"/></supplementary-material><supplementary-material content-type="local-data" id="SD9"><label>video2</label><media xlink:href="NIHMS789731-supplement-video2.avi" orientation="portrait" xlink:type="simple" id="d37e1079" position="anchor" mimetype="video"/></supplementary-material><supplementary-material content-type="local-data" id="SD10"><label>video3</label><media xlink:href="NIHMS789731-supplement-video3.avi" orientation="portrait" xlink:type="simple" id="d37e1083" position="anchor" mimetype="video"/></supplementary-material></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack id="S32"><p><text4fund><text><SENT sid="366" pm="."><plain>This study is supported by grants from US National Institutes of Health (R03AG044680 and 1R01NS089604 to X.W.), US Alzheimer’s Association (2014-NIRG-301299 to X.W.) and University Hospitals of Cleveland, USA (2012 SPITZ Innovation Pilot Grant to X.W.). </plain></SENT>
<SENT sid="367" pm="."><plain>Human spinal cord frozen tissues were obtained from the Eunice Kennedy Shriver National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders at the University of Maryland, USA contract HHSN275200900011C, Ref. </plain></SENT>
<SENT sid="368" pm="."><plain>No. N01-HD-9-0011. </plain></SENT>
<SENT sid="369" pm="."><plain>We also thank G. Perry and X. Zhu for providing paraffin-embedded human spinal cord tissues. </plain></SENT>
</text></text4fund></p></ack></SecTag><fn-group><SecTag type="AUTH_CONT"><fn id="FN3" fn-type="con"><p><text><SENT sid="372" pm="."><plain>Author contributions </plain></SENT>
</text></p><p><text><SENT sid="373" pm="."><plain>X.W. conceived and directed the project, interpreted results and wrote the manuscript. </plain></SENT>
<SENT sid="374" pm="."><plain>W.W., L.W., J.L., S.L.S, J.L., S.J., X.M., Z.J., M.S., H.C. and X.W. contributed to experiments, data analysis and manuscript preparation. </plain></SENT>
<SENT sid="375" pm="."><plain>H.F. contributed to electron microscopy study. </plain></SENT>
<SENT sid="376" pm="."><plain>E.L.daR. and H.L contributed to RNA-seq study. </plain></SENT>
<SENT sid="377" pm="."><plain>P.H.L. contributed to the reprogramming of human fibroblasts into human neurons. </plain></SENT>
</text></p></fn></SecTag><SecTag type="COMP_INT"><fn id="FN4" fn-type="conflict"><p><text><SENT sid="378" pm="."><plain>COMPETING FINANCIAL INTERESTS </plain></SENT>
</text></p><p><text><SENT sid="379" pm="."><plain>The authors declare no competing financial interests </plain></SENT>
</text></p></fn></SecTag></fn-group><SecTag type="REF"><ref-list><ref id="R1"><text><SENT sid="380" pm="."><plain>1SwinnenBRobberechtWThe phenotypic variability of amyotrophic lateral sclerosisNature reviews. </plain></SENT>
<SENT sid="381" pm="."><plain>Neurology10661670201425311585 </plain></SENT>
</text></ref><ref id="R2"><text><SENT sid="382" pm="."><plain>2RademakersRNeumannMMackenzieIRAdvances in understanding the molecular basis of frontotemporal dementiaNature reviews. </plain></SENT>
<SENT sid="383" pm="."><plain>Neurology8423434201222732773 </plain></SENT>
</text></ref><ref id="R3"><text><SENT sid="384" pm="?"><plain>3CleryABlatterMAllainFHRNA recognition motifs: boring? </plain></SENT>
<SENT sid="385" pm="."><plain>Not quiteCurrent opinion in structural biology18290298200818515081 </plain></SENT>
</text></ref><ref id="R4"><text><SENT sid="386" pm="."><plain>4BurattiEBaralleFEMultiple roles of TDP-43 in gene expression, splicing regulation, and human diseaseFrontiers in bioscience: a journal and virtual library13867878200817981595 </plain></SENT>
</text></ref><ref id="R5"><text><SENT sid="387" pm="."><plain>5BurattiEBaralleFETDP-43: gumming up neurons through protein-protein and protein-RNA interactionsTrends Biochem Sci37237247201222534659 </plain></SENT>
</text></ref><ref id="R6"><text><SENT sid="388" pm="."><plain>6LeeEBLeeVMTrojanowskiJQGains or losses: molecular mechanisms of TDP43-mediated neurodegenerationNature reviews. </plain></SENT>
<SENT sid="389" pm="."><plain>Neuroscience133850201222127299 </plain></SENT>
</text></ref><ref id="R7"><text><SENT sid="390" pm="."><plain>7KabashiETARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosisNat Genet40572574200818372902 </plain></SENT>
</text></ref><ref id="R8"><text><SENT sid="391" pm="."><plain>8SreedharanJTDP-43 mutations in familial and sporadic amyotrophic lateral sclerosisScience31916681672200818309045 </plain></SENT>
</text></ref><ref id="R9"><text><SENT sid="392" pm="."><plain>9NeumannMUbiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosisScience314130133200617023659 </plain></SENT>
</text></ref><ref id="R10"><text><SENT sid="393" pm="."><plain>10MackenzieIRRademakersRNeumannMTDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementiaThe Lancet. </plain></SENT>
<SENT sid="394" pm="."><plain>Neurology99951007201020864052 </plain></SENT>
</text></ref><ref id="R11"><text><SENT sid="395" pm="."><plain>11Amador-OrtizCTDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer’s diseaseAnnals of neurology61435445200717469117 </plain></SENT>
</text></ref><ref id="R12"><text><SENT sid="396" pm="."><plain>12JosephsKAStaging TDP-43 pathology in Alzheimer’s diseaseActa neuropathologica127441450201424240737 </plain></SENT>
</text></ref><ref id="R13"><text><SENT sid="397" pm="."><plain>13ChansonJBTDP43-positive intraneuronal inclusions in a patient with motor neuron disease and Parkinson’s diseaseNeurodegener Dis7260264201020197650 </plain></SENT>
</text></ref><ref id="R14"><text><SENT sid="398" pm="."><plain>14DavidsonYTDP-43 in ubiquitinated inclusions in the inferior olives in frontotemporal lobar degeneration and in other neurodegenerative diseases: a degenerative process distinct from normal ageingActa Neuropathol118359369200919330339 </plain></SENT>
</text></ref><ref id="R15"><text><SENT sid="399" pm="."><plain>15ArnoldESALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43Proceedings of the National Academy of Sciences of the United States of America110E736745201323382207 </plain></SENT>
</text></ref><ref id="R16"><text><SENT sid="400" pm="."><plain>16AustinJADisease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-lifeProceedings of the National Academy of Sciences of the United States of America11143094314201424591609 </plain></SENT>
</text></ref><ref id="R17"><text><SENT sid="401" pm="."><plain>17BarmadaSJCytoplasmic Mislocalization of TDP-43 Is Toxic to Neurons and Enhanced by a Mutation Associated with Familial Amyotrophic Lateral SclerosisJournal of Neuroscience30639649201020071528 </plain></SENT>
</text></ref><ref id="R18"><text><SENT sid="402" pm="."><plain>18Hansson PetersenCAThe amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristaeProceedings of the National Academy of Sciences of the United States of America1051314513150200818757748 </plain></SENT>
</text></ref><ref id="R19"><text><SENT sid="403" pm="."><plain>19EmanuelssonOBrunakSvon HeijneGNielsenHLocating proteins in the cell using TargetP, SignalP and related toolsNature protocols2953971200717446895 </plain></SENT>
</text></ref><ref id="R20"><text><SENT sid="404" pm="."><plain>20ClarosMGVincensPComputational method to predict mitochondrially imported proteins and their targeting sequencesEuropean journal of biochemistry/FEBS24177978619968944766 </plain></SENT>
</text></ref><ref id="R21"><text><SENT sid="405" pm="."><plain>21BolenderNSickmannAWagnerRMeisingerCPfannerNMultiple pathways for sorting mitochondrial precursor proteinsEMBO reports94249200818174896 </plain></SENT>
</text></ref><ref id="R22"><text><SENT sid="406" pm="."><plain>22SchmidtOPfannerNMeisingerCMitochondrial protein import: from proteomics to functional mechanismsNat Rev Mol Cell Biol11655667201020729931 </plain></SENT>
</text></ref><ref id="R23"><text><SENT sid="407" pm="."><plain>23SillerudLOLarsonRSDesign and structure of peptide and peptidomimetic antagonists of protein-protein interactionCurrent protein &amp; peptide science6151169200515853652 </plain></SENT>
</text></ref><ref id="R24"><text><SENT sid="408" pm="."><plain>24HerdewynSPrevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T) miceMol Neurodegener924201424938805 </plain></SENT>
</text></ref><ref id="R25"><text><SENT sid="409" pm="."><plain>25HatzipetrosTC57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALSBrain research15845972201424141148 </plain></SENT>
</text></ref><ref id="R26"><text><SENT sid="410" pm="."><plain>26DangTNIncreased metal content in the TDP-43(A315T) transgenic mouse model of frontotemporal lobar degeneration and amyotrophic lateral sclerosisFront Aging Neurosci615201424575040 </plain></SENT>
</text></ref><ref id="R27"><text><SENT sid="411" pm="."><plain>27DangTNEndogenous progesterone levels and frontotemporal dementia: modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse modelDisease models &amp; mechanisms611981204201323798570 </plain></SENT>
</text></ref><ref id="R28"><text><SENT sid="412" pm="."><plain>28WegorzewskaIBellSCairnsNJMillerTMBalohRHTDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degenerationProceedings of the National Academy of Sciences of the United States of America1061880918814200919833869 </plain></SENT>
</text></ref><ref id="R29"><text><SENT sid="413" pm="."><plain>29MoriFMaturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementiaActa neuropathologica116193203200818560845 </plain></SENT>
</text></ref><ref id="R30"><text><SENT sid="414" pm="."><plain>30HasegawaMPhosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosisAnnals of neurology646070200818546284 </plain></SENT>
</text></ref><ref id="R31"><text><SENT sid="415" pm="."><plain>31BrandmeirNJSevere subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron diseaseActa neuropathologica115123131200818004574 </plain></SENT>
</text></ref><ref id="R32"><text><SENT sid="416" pm="."><plain>32YangCPartial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosisProceedings of the National Academy of Sciences of the United States of America111E11211129201424616503 </plain></SENT>
</text></ref><ref id="R33"><text><SENT sid="417" pm="."><plain>33WuLSChengWCShenCKTargeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in miceThe Journal of biological chemistry2872733527344201222718760 </plain></SENT>
</text></ref><ref id="R34"><text><SENT sid="418" pm="."><plain>34PfefferSWoellhafMWHerrmannJMForsterFOrganization of the mitochondrial translation machinery studied in situ by cryoelectron tomographyNature communications660192015 </plain></SENT>
</text></ref><ref id="R35"><text><SENT sid="419" pm="."><plain>35PolymenidouMLong pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43Nature neuroscience14459468201121358643 </plain></SENT>
</text></ref><ref id="R36"><text><SENT sid="420" pm="."><plain>36SephtonCFIdentification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexesThe Journal of biological chemistry28612041215201121051541 </plain></SENT>
</text></ref><ref id="R37"><text><SENT sid="421" pm="."><plain>37TollerveyJRCharacterizing the RNA targets and position-dependent splicing regulation by TDP-43Nature neuroscience14452458201121358640 </plain></SENT>
</text></ref><ref id="R38"><text><SENT sid="422" pm="."><plain>38NarayananRKIdentification of RNA bound to the TDP-43 ribonucleoprotein complex in the adult mouse brainAmyotrophic lateral sclerosis &amp; frontotemporal degeneration14252260201323134510 </plain></SENT>
</text></ref><ref id="R39"><text><SENT sid="423" pm="."><plain>39McFarlandRDe novo mutations in the mitochondrial ND3 gene as a cause of infantile mitochondrial encephalopathy and complex I deficiencyAnnals of neurology555864200414705112 </plain></SENT>
</text></ref><ref id="R40"><text><SENT sid="424" pm="."><plain>40ChinneryPFThe mitochondrial ND6 gene is a hot spot for mutations that cause Leber’s hereditary optic neuropathyBrain: a journal of neurology124209218200111133798 </plain></SENT>
</text></ref><ref id="R41"><text><SENT sid="425" pm="."><plain>41LiuWPink1 regulates the oxidative phosphorylation machinery via mitochondrial fissionProc Natl Acad Sci U S A1081292012924201121768365 </plain></SENT>
</text></ref><ref id="R42"><text><SENT sid="426" pm="."><plain>42CogliatiSMitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiencyCell155160171201324055366 </plain></SENT>
</text></ref><ref id="R43"><text><SENT sid="427" pm="."><plain>43XuYFWild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic miceJ Neurosci301085110859201020702714 </plain></SENT>
</text></ref><ref id="R44"><text><SENT sid="428" pm="."><plain>44XuYFExpression of mutant TDP-43 induces neuronal dysfunction in transgenic miceMol Neurodegener673201122029574 </plain></SENT>
</text></ref><ref id="R45"><text><SENT sid="429" pm="."><plain>45MagraneJCortezCGanWBManfrediGAbnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse modelsHuman molecular genetics2013 </plain></SENT>
</text></ref><ref id="R46"><text><SENT sid="430" pm="."><plain>46WangWThe ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neuronsHuman molecular genetics2247064719201323827948 </plain></SENT>
</text></ref><ref id="R47"><text><SENT sid="431" pm="."><plain>47KroemerGDallaportaBResche-RigonMThe mitochondrial death/life regulator in apoptosis and necrosisAnnu Rev Physiol6061964219989558479 </plain></SENT>
</text></ref><ref id="R48"><text><SENT sid="432" pm="."><plain>48GalluzziLKroemerGNecroptosis: A Specialized Pathway of Programmed NecrosisCell13511611163200819109884 </plain></SENT>
</text></ref><ref id="R49"><text><SENT sid="433" pm="."><plain>49DolmetschRGeschwindDHThe Human Brain in a Dish: The Promise of iPSC-Derived NeuronsCell145831834201121663789 </plain></SENT>
</text></ref><ref id="R50"><text><SENT sid="434" pm="."><plain>50MillerJDHuman iPSC-Based Modeling of Late-Onset Disease via Progerin-Induced AgingCell stem cell13691705201324315443 </plain></SENT>
</text></ref><ref id="R51"><text><SENT sid="435" pm="."><plain>51ZhuXWActivation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer diseaseJournal of neuropathology and experimental neurology59880888200011079778 </plain></SENT>
</text></ref><ref id="R52"><text><SENT sid="436" pm="."><plain>52KaechSBankerGCulturing hippocampal neuronsNat Protoc124062415200617406484 </plain></SENT>
</text></ref><ref id="R53"><text><SENT sid="437" pm="."><plain>53WangXSuBFujiokaHZhuXDynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer’s disease patientsThe American journal of pathology173470482200818599615 </plain></SENT>
</text></ref><ref id="R54"><text><SENT sid="438" pm="."><plain>54LuJJThe Distribution of Genomic Variations in Human iPSCs Is Related to Replication-Timing Reorganization during ReprogrammingCell Rep77078201424685138 </plain></SENT>
</text></ref><ref id="R55"><text><SENT sid="439" pm="."><plain>55ChoiSWGerencserAANichollsDGBioenergetic analysis of isolated cerebrocortical nerve terminals on a microgram scale: spare respiratory capacity and stochastic mitochondrial failureJournal of neurochemistry10911791191200919519782 </plain></SENT>
</text></ref><ref id="R56"><text><SENT sid="440" pm="."><plain>56WangXImpaired balance of mitochondrial fission and fusion in Alzheimer’s diseaseJ Neurosci2990909103200919605646 </plain></SENT>
</text></ref><ref id="R57"><text><SENT sid="441" pm="."><plain>57KirbyDMThorburnDRTurnbullDMTaylorRWBiochemical assays of respiratory chain complex activityMethods in cell biology8093119200717445690 </plain></SENT>
</text></ref><ref id="R58"><text><SENT sid="442" pm="."><plain>58JonesBJRobertsDJA rotarod suitable for quantitative measurements of motor incoordination in naive miceNaunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie25921119684232694 </plain></SENT>
</text></ref><ref id="R59"><text><SENT sid="443" pm="."><plain>59FujiokaHDecreased cytochrome c oxidase subunit VIIa in aged rat heart mitochondria: immunocytochemistryAnatomical record294182518332011 </plain></SENT>
</text></ref><ref id="R60"><text><SENT sid="444" pm="."><plain>60HanaichiTA stable lead by modification of Sato’s methodJournal of electron microscopy3530430619862440973 </plain></SENT>
</text></ref><ref id="R61"><text><SENT sid="445" pm="."><plain>61FujiokaHTandlerBHoppelCLMitochondrial division in rat cardiomyocytes: an electron microscope studyAnatomical record295145514612012 </plain></SENT>
</text></ref><ref id="R62"><text><SENT sid="446" pm="."><plain>62WangXAmyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteinsProceedings of the National Academy of Sciences of the United States of America1051931819323200819050078 </plain></SENT>
</text></ref></ref-list></SecTag></back><floats-group><SecTag type="FIG"><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>TDP-43 co-localizes with and accumulates in mitochondria in individuals with ALS and FTD</title><p><text><SENT sid="447" pm="."><plain>(a,b) Representative images of TOM20 and TDP-43 in human motor neurons in lumbar spinal cords of sporadic ALS (n = 6) (a), or human cortical neurons in cortices of sporadic FTD (n = 4) (b). </plain></SENT>
<SENT sid="448" pm="."><plain>Control neurons are from age-matched normal individuals (n = 5 for spinal cords and 3 for cortices). </plain></SENT>
<SENT sid="449" pm="."><plain>Right panels show line-scan analysis (by Image J RGB Profile Plot plugin) along the solid white lines depicted in the merged images to the left. </plain></SENT>
<SENT sid="450" pm="."><plain>(c,d) Reconstructed three-dimension (3D) images of the neurons depicted in a and b, respectively. </plain></SENT>
<SENT sid="451" pm="."><plain>(e, f) Representative immunoblot and quantification (n = 3) of TDP-43 levels in mitochondria isolated from age matched control (n = 6) and sporadic ALS (n = 8) spinal cords (e), or age matched control (n = 6) and sporadic FTD (n = 7) cortices (f). </plain></SENT>
<SENT sid="452" pm="."><plain>(g,h) Representative immunoblot (n = 3) of TDP-43 in sub-mitochondrial fractions prepared from ALS spinal cords (g) and FTD cortices (h). </plain></SENT>
<SENT sid="453" pm="."><plain>(i) Immuno-EM of TDP-43 in mitochondria from sporadic ALS spinal cord or sporadic FTD cortex. </plain></SENT>
<SENT sid="454" pm="."><plain>Red arrowheads point to immunogold labeled TDP-43. </plain></SENT>
<SENT sid="455" pm="."><plain>The right panel shows quantification using thin EM sections with 50 nm thickness. n = 8, 6, 6 and 6 respectively. </plain></SENT>
<SENT sid="456" pm="."><plain>Data are means ± s.e.m of triplicate independent experiments throughout. </plain></SENT>
<SENT sid="457" pm="."><plain>Statistics: one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparison test. *P &lt; 0.05, **P &lt; 0.01 and ***P &lt; 0.001. </plain></SENT>
</text></p></caption><graphic xlink:href="nihms789731f1"/></fig></SecTag><SecTag type="FIG"><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><title>ALS-associated genetic mutations in TDP-43 increase its import into mitochondria</title><p><text><SENT sid="458" pm="."><plain>(a–c) Representative immunoblot and quantification (n = 3) of TDP-43 in mitochondria from human fibroblasts (a), HEK293 cells expressing Flag tagged human WT and mutant TDP-43 (b, arrowhead indicates exogenous Flag-tagged TDP-43), or spinal cords and brains of 1–2 month old transgenic male mice expressing WT or mutant human TDP-43 (hTDP-43) (n = 6 per group) (c). </plain></SENT>
<SENT sid="459" pm="."><plain>(d, e) Representative immunoblot (n = 3) of TDP-43 in sub-mitochondrial fractions of human fibroblasts (d) or transgenic mice (e). </plain></SENT>
<SENT sid="460" pm="."><plain>(f) Representative immunoblot (n = 3) of rTDP-43 (left panel) or biotinylated F1β (right panel) in freshly isolated mitochondria from mouse brain after mitochondrial import assay. </plain></SENT>
<SENT sid="461" pm="."><plain>(g) Representative immunoblot and quantification (n = 3) of rTDP-43 in freshly isolated mitochondria from mouse brain after incubation with rTDP-43 at indicated times followed by trypsin and digitonin co-treatment. </plain></SENT>
<SENT sid="462" pm="."><plain>(h) Immuno-EM analysis of rTDP-43 in purified mouse brain mitochondria after mitochondrial import assay (no post-import treatment). </plain></SENT>
<SENT sid="463" pm="."><plain>Red arrowheads point to immunogold labeled TDP-43. </plain></SENT>
<SENT sid="464" pm="."><plain>The right panel shows quantification using thin EM sections with 50 nm thickness. n = 14 for WT and 16 for A315T. </plain></SENT>
<SENT sid="465" pm="."><plain>Data are means ± s.e.m of triplicate experiments. </plain></SENT>
<SENT sid="466" pm="."><plain>Statistics: one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparison test. *P &lt; 0.05, ***P &lt; 0.001 and ****P &lt; 0.0001. </plain></SENT>
<SENT sid="467" pm="."><plain>In panel g, *P &lt; 0.05, compared with WT TDP-43. </plain></SENT>
</text></p></caption><graphic xlink:href="nihms789731f2"/></fig></SecTag><SecTag type="FIG"><fig id="F3" orientation="portrait" position="float"><label>Figure 3</label><caption><title>TDP-43 mitochondrial import depends on TOM-TIM23 complex and internal M1, M3 and M5 motifs</title><p><text><SENT sid="468" pm="."><plain>(a) The structure (top panel) and the amino acid sequence (bottom panel) of human TDP-43. </plain></SENT>
<SENT sid="469" pm="."><plain>RRM1 and RRM2 are RNA recognition motifs. </plain></SENT>
<SENT sid="470" pm="."><plain>NLS: nuclear localization sequence; NES: nuclear export sequence. </plain></SENT>
<SENT sid="471" pm="."><plain>(b) Representative immunoblot and quantification (n = 3) of rTDP-43 in mouse brain mitochondria after incubation with indicated rTDP-43 deletions of putative internal targeting signals (ΔM1–6) followed by trypsin and digitonin co-treatment. </plain></SENT>
<SENT sid="472" pm="."><plain>(c) Representative immunoblot and quantification (n = 3) of TDP-43 in mitochondria from HEK293 cells overexpressing Flag tagged TDP-43 (ΔM1–6) using anti-Flag antibody. </plain></SENT>
<SENT sid="473" pm="."><plain>(d) Representative immunoblot and quantification (n = 3) of Flag tagged rTDP-43 and pF1β in mitochondria that were pre- or co-treated with 5 μM control peptide (cPM), PM1 or PM3, followed by mitochondrial import assay using rTDP-43 or pF1β incubation. </plain></SENT>
<SENT sid="474" pm="."><plain>(e,f) Representative immunoblot and quantification (n = 3) of TDP-43 in mitochondria from HEK293 cells (e) or rat primary cortical neurons (12 days in vitro: DIV 12, f) treated with 1 μM cPM, PM1 or PM3 for 24 hours. </plain></SENT>
<SENT sid="475" pm="."><plain>(g) Representative immunoblot and quantification (n = 3) of GFP in isolated mitochondria from HEK293 cells expressing GFP or M1, M3 and M5-GFP (N-terminus tag). </plain></SENT>
<SENT sid="476" pm="."><plain>HEK293 cells were collected two days after transient transfection. </plain></SENT>
<SENT sid="477" pm="."><plain>Quantification is based on samples co-treated with trypsin and digitonin. </plain></SENT>
<SENT sid="478" pm="."><plain>Data are means ± s.e.m of triplicate experiments. </plain></SENT>
<SENT sid="479" pm="."><plain>Statistics: one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparison test. *P &lt; 0.05. </plain></SENT>
</text></p></caption><graphic xlink:href="nihms789731f3"/></fig></SecTag><SecTag type="FIG"><fig id="F4" orientation="portrait" position="float"><label>Figure 4</label><caption><title>TDP-43 preferentially binds mitochondria-transcribed ND3 and ND6 mRNAs and inhibits their translation</title><p><text><SENT sid="480" pm="."><plain>(a) Map of the human mitochondrial genome. </plain></SENT>
<SENT sid="481" pm="."><plain>The directions of DNA replication or transcription are indicated by arrows. </plain></SENT>
<SENT sid="482" pm="."><plain>Mitochondrial genome encodes 2 rRNAs, 22 tRNAs and 13 subunits essential for 4 OXPHOS complexes. </plain></SENT>
<SENT sid="483" pm="."><plain>(b–d) Representative reverse transcriptase-coupled quantitative real time polymerase chain reaction (qRT-PCR) analysis (n = 3) of mitochondrial encoded mRNAs precipitated by TDP-43 or Flag antibody in mitochondria from 3 month old mouse brain (b), human fibroblasts (c) or HEK293 cells overexpressing Flag tagged hTDP-43 (d). </plain></SENT>
<SENT sid="484" pm="."><plain>(e) Representative immunoblot and quantification (n = 3) of mitochondrial encoded protein translation in HEK293 cells expressing TDP-43 WT or ΔM1. </plain></SENT>
<SENT sid="485" pm="."><plain>Cells were metabolically labelled with AHA (50 μM) in the presence of emetine (0.1 mg per ml). </plain></SENT>
<SENT sid="486" pm="."><plain>Following mitochondrial purification, AHA labelled proteins were tagged with biotin-alkyne and finally analyzed by immunoblot using streptavidin conjugates. </plain></SENT>
<SENT sid="487" pm="."><plain>(f–h) Representative immunoblot and quantification (n = 3) of the expression of mitochondrial encoded proteins in HEK293 cells (f), human fibroblasts treated with 1 μM cPM (scrambled M1) or PM1 for 48 hours (g), and spinal cords from ALS (n = 8) and age-matched normal individuals (n = 6) (h). </plain></SENT>
<SENT sid="488" pm="."><plain>Data are means ± s.e.m of triplicate experiments. </plain></SENT>
<SENT sid="489" pm="."><plain>Statistics: one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparison test. *P &lt; 0.05, **P &lt; 0.01 and ***P &lt; 0.001. </plain></SENT>
<SENT sid="490" pm="."><plain>In panel f, *P &lt; 0.05, compared with control cells and #P &lt; 0.05, compared with cells expressing WT TDP-43. </plain></SENT>
</text></p></caption><graphic xlink:href="nihms789731f4"/></fig></SecTag><SecTag type="FIG"><fig id="F5" orientation="portrait" position="float"><label>Figure 5</label><caption><title>TDP-43 specifically reduces complex I assembly and impairs mitochondrial function and morphology</title><p><text><SENT sid="491" pm="."><plain>Representative images and quantification (n = 3) of complex I or I–V assembly (a,c) and activities (b,d) in HEK293 cells overexpressing Flag tagged TDP-43 (a,b), and human fibroblasts 48 hours after 1 μM cPM (scrambled M1) or PM1 treatment (c, d). </plain></SENT>
<SENT sid="492" pm="."><plain>Arrowheads point to complex I. (e) Measurements (n = 3) of OXPHOS complex I activity in mitochondria from HEK293 cells overexpressing Flag tagged WT TDP-43, ND3 and ND6. </plain></SENT>
<SENT sid="494" pm="."><plain>(f) Measurements (n = 3, normalized by total protein) of mΔψ (by TMRM), ATP production and OCR in human fibroblasts 48 hours after 1μM cPM (scrambled M1) or PM1 treatment. </plain></SENT>
<SENT sid="495" pm="."><plain>(g) Representative confocal images and quantification (n = 3) of mitochondrial length in human fibroblasts. </plain></SENT>
<SENT sid="496" pm="."><plain>Fibroblasts were transfected with mitoDsRed2 (a mitochondrial specifically localized red fluorescent protein) to label mitochondria. </plain></SENT>
<SENT sid="497" pm="."><plain>Nuclei were stained by DAPI. n = 50 cells per group. </plain></SENT>
<SENT sid="498" pm="."><plain>(f) Measurement (n = 3) of the sensitivity of human fibroblasts to H2O2. </plain></SENT>
<SENT sid="499" pm="."><plain>Fibroblasts were pre-treated with 1 μM cPM or PM1. </plain></SENT>
<SENT sid="500" pm="."><plain>48 hours after pre-treatment, fibroblasts were treated with 50 μM H2O2 for 1 hour and LDH assay performed after 3 hours of recovery. </plain></SENT>
<SENT sid="501" pm="."><plain>Data are means ± s.e.m of triplicate experiments. </plain></SENT>
<SENT sid="502" pm="."><plain>Statistics: one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparison test. *P &lt; 0.05. </plain></SENT>
<SENT sid="503" pm="."><plain>In panel a and b, *P &lt; 0.05, compared with control cells and #P &lt; 0.05, compared with cells expressing WT TDP-43. </plain></SENT>
</text></p></caption><graphic xlink:href="nihms789731f5"/></fig></SecTag><SecTag type="FIG"><fig id="F6" orientation="portrait" position="float"><label>Figure 6</label><caption><title>Suppression of TDP-43 mitochondrial localization abolishes TDP-43 neurotoxicity</title><p><text><SENT sid="504" pm="."><plain>(a) Schematic and representative image showing 3 months old mice injected with bicistronic lentivirus encoding both TDP-43 and mitoDsRed2 into the motor cortex. </plain></SENT>
<SENT sid="505" pm="."><plain>Arrow points the injection site. </plain></SENT>
<SENT sid="506" pm="."><plain>(b) Representative 2D (upper) and 3D (lower, enlargements) images and quantification (n = 3) of mitochondrial length. n = 45, 50, 40, 33 and 35 neurons for vector, WT, WT ΔM1, A315T and A315T ΔM1 expressing neurons respectively from 6 mice (3-month-old, equal male and female) per group. </plain></SENT>
<SENT sid="507" pm="."><plain>(c) Representative immunostaining and quantification of cleaved caspase 3 positive neurons. n = 35, 37, 33, 33 and 32 neurons for vector, WT, WT ΔM1, A315T and A315T ΔM1 respectively. </plain></SENT>
<SENT sid="508" pm="."><plain>(d) ND3 and ND6 expression in spinal cords of 70 day old male non-transgenic (NTG) and TDP-43 A315T transgenic mice (n = 6 mice per group). </plain></SENT>
<SENT sid="509" pm="."><plain>(e,f) OCR and mΔψ (e) and OXPHOS complex assembly (f) in synaptic mitochondria in 70 day old male mice (n = 4 mice per group). </plain></SENT>
<SENT sid="510" pm="."><plain>Motor neuron counts in lumbar spinal cords (g), NMJs in gastrocnemius muscles (h, SV2: synaptic vesicle protein 2; 2H3: neurofilament), footprints (i, arrow points the walking direction) and rotarod performance (j) of 70 day old male mice (n = 6 mice per group). </plain></SENT>
<SENT sid="511" pm="."><plain>For d–j, treatments began from 60 day old. </plain></SENT>
<SENT sid="512" pm="."><plain>Data are means ± s.e.m of triplicate experiments. </plain></SENT>
<SENT sid="513" pm="."><plain>Statistics: one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparison test. *P &lt; 0.05, **P &lt; 0.01 and ***P &lt; 0.001. </plain></SENT>
</text></p></caption><graphic xlink:href="nihms789731f6"/></fig></SecTag><SecTag type="TABLE"><table-wrap id="T1" position="float" orientation="landscape"><label>Table 1</label><caption><p><text><SENT sid="514" pm="."><plain>Information of fixed and frozen brain and spinal cord tissues. </plain></SENT>
</text></p></caption><table frame="box" rules="all"><thead><tr><th colspan="6" valign="top" align="left" rowspan="1"><text><SENT sid="515" pm="."><plain>Paraffin sections for immunocytochemistry and immunofluorescence </plain></SENT>
</text></th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="516" pm="."><plain>Diagnosis </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="517" pm="."><plain>Age (years) </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="518" pm="."><plain>TDP-43 pathology </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="519" pm="."><plain>Diagnosis </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="520" pm="."><plain>Age (years) </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="521" pm="."><plain>TDP-43 pathology </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="522" pm="."><plain>ALS </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="523" pm="."><plain>N/A </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="524" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="525" pm="."><plain>FTD </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="526" pm="."><plain>74 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="527" pm="."><plain>Yes </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="528" pm="."><plain>ALS </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="529" pm="."><plain>N/A </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="530" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="531" pm="."><plain>FTD </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="532" pm="."><plain>78 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="533" pm="."><plain>Yes </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="534" pm="."><plain>ALS </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="535" pm="."><plain>80 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="536" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="537" pm="."><plain>FTD </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="538" pm="."><plain>79 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="539" pm="."><plain>Yes </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="540" pm="."><plain>ALS </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="541" pm="."><plain>N/A </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="542" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="543" pm="."><plain>FTD </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="544" pm="."><plain>88 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="545" pm="."><plain>Yes </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="546" pm="."><plain>ALS </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="547" pm="."><plain>49 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="548" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="549" pm="."><plain>Control </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="550" pm="."><plain>70 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="551" pm="."><plain>None </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="552" pm="."><plain>ALS </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="553" pm="."><plain>N/A </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="554" pm="."><plain>Yes </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="555" pm="."><plain>Control </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="556" pm="."><plain>74 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="557" pm="."><plain>None </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="558" pm="."><plain>Control </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="559" pm="."><plain>52 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="560" pm="."><plain>None </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="561" pm="."><plain>Control </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="562" pm="."><plain>81 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="563" pm="."><plain>None </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="564" pm="."><plain>Control </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="565" pm="."><plain>64 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="566" pm="."><plain>None </plain></SENT>
</text></td><td rowspan="4" colspan="3" align="left" valign="top"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="567" pm="."><plain>Control </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="568" pm="."><plain>63 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="569" pm="."><plain>None </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="570" pm="."><plain>Control </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="571" pm="."><plain>38 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="572" pm="."><plain>None </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="573" pm="."><plain>Control </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="574" pm="."><plain>55 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="575" pm="."><plain>None </plain></SENT>
</text></td></tr></tbody></table><table frame="box" rules="all"><thead><tr><th colspan="9" valign="top" align="left" rowspan="1"><text><SENT sid="576" pm="."><plain>Frozen tissue samples for biochemical analysis </plain></SENT>
</text></th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="577" pm="."><plain>UMB# </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="578" pm="."><plain>Diagnosis </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="579" pm="."><plain>Age (years) </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="580" pm="."><plain>Sex </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="581" pm="."><plain>PMI (hours) </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="582" pm="."><plain>Diagnosis </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="583" pm="."><plain>Age (years) </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="584" pm="."><plain>Sex </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="585" pm="."><plain>PMI (hours) </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="586" pm="."><plain>4627 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="587" pm="."><plain>ALS </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="588" pm="."><plain>41 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="589" pm="."><plain>M </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="590" pm="."><plain>21 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="591" pm="."><plain>FTD </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="592" pm="."><plain>81 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="593" pm="."><plain>M </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="594" pm="."><plain>12 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="595" pm="."><plain>4768 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="596" pm="."><plain>ALS </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="597" pm="."><plain>45 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="598" pm="."><plain>M </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="599" pm="."><plain>19 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="600" pm="."><plain>FTD </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="601" pm="."><plain>62 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="602" pm="."><plain>F </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="603" pm="."><plain>12 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="604" pm="."><plain>4528 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="605" pm="."><plain>ALS </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="606" pm="."><plain>49 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="607" pm="."><plain>M </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="608" pm="."><plain>9 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="609" pm="."><plain>FTD </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="610" pm="."><plain>59 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="611" pm="."><plain>M </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="612" pm="."><plain>12 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="613" pm="."><plain>4762 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="614" pm="."><plain>ALS </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="615" pm="."><plain>59 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="616" pm="."><plain>M </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="617" pm="."><plain>6 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="618" pm="."><plain>FTD </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="619" pm="."><plain>77 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="620" pm="."><plain>M </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="621" pm="."><plain>4 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="622" pm="."><plain>5004 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="623" pm="."><plain>ALS </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="624" pm="."><plain>61 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="625" pm="."><plain>F </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="626" pm="."><plain>22 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="627" pm="."><plain>FTD </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="628" pm="."><plain>76 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="629" pm="."><plain>F </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="630" pm="."><plain>4 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="631" pm="."><plain>5388 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="632" pm="."><plain>ALS </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="633" pm="."><plain>61 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="634" pm="."><plain>M </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="635" pm="."><plain>8 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="636" pm="."><plain>FTD </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="637" pm="."><plain>98 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="638" pm="."><plain>F </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="639" pm="."><plain>23 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="640" pm="."><plain>4871 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="641" pm="."><plain>ALS </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="642" pm="."><plain>70 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="643" pm="."><plain>M </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="644" pm="."><plain>14 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="645" pm="."><plain>FTD </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="646" pm="."><plain>63 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="647" pm="."><plain>F </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="648" pm="."><plain>11 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="649" pm="."><plain>4872 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="650" pm="."><plain>ALS </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="651" pm="."><plain>71 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="652" pm="."><plain>F </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="653" pm="."><plain>6 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="654" pm="."><plain>Control </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="655" pm="."><plain>77 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="656" pm="."><plain>M </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="657" pm="."><plain>23 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="658" pm="."><plain>145 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="659" pm="."><plain>Control </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="660" pm="."><plain>48 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="661" pm="."><plain>M </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="662" pm="."><plain>21 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="663" pm="."><plain>Control </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="664" pm="."><plain>86 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="665" pm="."><plain>F </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="666" pm="."><plain>13 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="667" pm="."><plain>5399 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="668" pm="."><plain>Control </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="669" pm="."><plain>50 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="670" pm="."><plain>M </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="671" pm="."><plain>17 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="672" pm="."><plain>Control </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="673" pm="."><plain>78 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="674" pm="."><plain>M </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="675" pm="."><plain>5 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="676" pm="."><plain>1471 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="677" pm="."><plain>Control </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="678" pm="."><plain>55 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="679" pm="."><plain>M </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="680" pm="."><plain>24 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="681" pm="."><plain>Control </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="682" pm="."><plain>89 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="683" pm="."><plain>F </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="684" pm="."><plain>5 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="685" pm="."><plain>840 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="686" pm="."><plain>Control </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="687" pm="."><plain>58 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="688" pm="."><plain>M </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="689" pm="."><plain>18 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="690" pm="."><plain>Control </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="691" pm="."><plain>74 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="692" pm="."><plain>F </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="693" pm="."><plain>6 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="694" pm="."><plain>946 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="695" pm="."><plain>Control </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="696" pm="."><plain>69 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="697" pm="."><plain>M </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="698" pm="."><plain>12 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="699" pm="."><plain>Control </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="700" pm="."><plain>68 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="701" pm="."><plain>F </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="702" pm="."><plain>1 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="703" pm="."><plain>5572 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="704" pm="."><plain>Control </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="705" pm="."><plain>70 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="706" pm="."><plain>F </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="707" pm="."><plain>24 </plain></SENT>
</text></td><td colspan="4" align="left" valign="top" rowspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>Note: all ALS and FTD cases used are sporadic and no known genetic mutation in any gene is noted.</p></fn></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="T2" position="float" orientation="portrait"><label>Table 2</label><caption><title>Sequences of nuclear format ND3/6 and primers</title><p><text><SENT sid="708" pm="."><plain>(a) Sequences of ND3 and ND6 in nuclear format with N-terminal mitochondrial targeting sequence and/or C-terminal myc tag. </plain></SENT>
<SENT sid="709" pm="."><plain>(b) Primers used for mitochondrial encodes RNAs, CFTR assay and Tim22/23 RNAi. </plain></SENT>
<SENT sid="710" pm="."><plain>esiRNAi: endoribonuclease-pepared siRNAs. </plain></SENT>
</text></p></caption><table frame="void" rules="none"><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="711" pm="."><plain> </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="T3" position="float" orientation="portrait"><label>Table 3</label><caption><p><text><SENT sid="712" pm="."><plain>Antibodies used in this study. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="713" pm="."><plain>Antibody </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="714" pm="."><plain>Application </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="715" pm="."><plain>Host </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="716" pm="."><plain>Source </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="717" pm="."><plain>Catalogue# </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="718" pm="."><plain>58K-9 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="719" pm="."><plain>IF </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="720" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="721" pm="."><plain>Abcam </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="722" pm="."><plain>ab27043 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="723" pm="."><plain>ATP5A </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="724" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="725" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="726" pm="."><plain>Abcam </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="727" pm="."><plain>ab14748 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="728" pm="."><plain>Calnexin </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="729" pm="."><plain>WB/IF </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="730" pm="."><plain>Rabbit monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="731" pm="."><plain>Cell Signaling </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="732" pm="."><plain>2679 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="733" pm="."><plain>Calreticulin </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="734" pm="."><plain>IF </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="735" pm="."><plain>Rabbit monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="736" pm="."><plain>Cell Signaling </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="737" pm="."><plain>12238 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="738" pm="."><plain>Cleaved caspase3 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="739" pm="."><plain>WB/IF/IHC </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="740" pm="."><plain>Rabbit monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="741" pm="."><plain>Cell Signaling </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="742" pm="."><plain>9664 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="743" pm="."><plain>COX I </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="744" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="745" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="746" pm="."><plain>Abcam </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="747" pm="."><plain>ab14705 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="748" pm="."><plain>COX II </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="749" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="750" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="751" pm="."><plain>Abcam </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="752" pm="."><plain>ab110258 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="753" pm="."><plain>COX III </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="754" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="755" pm="."><plain>Rabbit polyclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="756" pm="."><plain>Sigma </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="757" pm="."><plain>HPA042788 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="758" pm="."><plain>COX IV </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="759" pm="."><plain>WB/IF </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="760" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="761" pm="."><plain>Cell Signaling </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="762" pm="."><plain>11967 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="763" pm="."><plain>COX IV </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="764" pm="."><plain>WB/IF </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="765" pm="."><plain>Rabbit monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="766" pm="."><plain>Cell Signaling </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="767" pm="."><plain>4850 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="768" pm="."><plain>Cytochrome b </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="769" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="770" pm="."><plain>Rabbit polyclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="771" pm="."><plain>Santa Cruz </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="772" pm="."><plain>SC-11436 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="773" pm="."><plain>Cytochrome c </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="774" pm="."><plain>WB/IF </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="775" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="776" pm="."><plain>BD Biosciences </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="777" pm="."><plain>556432 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="778" pm="."><plain>F1β/ATP5B </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="779" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="780" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="781" pm="."><plain>Abcam </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="782" pm="."><plain>ab14730 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="783" pm="."><plain>Flag </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="784" pm="."><plain>WB/IF/IHC </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="785" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="786" pm="."><plain>Sigma </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="787" pm="."><plain>F1804 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="788" pm="."><plain>GAPDH </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="789" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="790" pm="."><plain>Rabbit monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="791" pm="."><plain>Cell Signaling </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="792" pm="."><plain>2118 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="793" pm="."><plain>GFAP </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="794" pm="."><plain>IHC </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="795" pm="."><plain>Rabbit polyclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="796" pm="."><plain>Invitrogen </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="797" pm="."><plain>18-0063 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="798" pm="."><plain>GFP </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="799" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="800" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="801" pm="."><plain>Santa Cruz </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="802" pm="."><plain>sc-9996 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="803" pm="."><plain>HDAC1 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="804" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="805" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="806" pm="."><plain>Cell Signaling </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="807" pm="."><plain>5356 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="808" pm="."><plain>HSP60 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="809" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="810" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="811" pm="."><plain>ProteinTech </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="812" pm="."><plain>66041-1-Ig </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="813" pm="."><plain>LAMP2 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="814" pm="."><plain>IF </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="815" pm="."><plain>Rat monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="816" pm="."><plain>Abcam </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="817" pm="."><plain>ab25339 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="818" pm="."><plain>LC3 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="819" pm="."><plain>IF </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="820" pm="."><plain>Rabbit monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="821" pm="."><plain>Cell Signaling </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="822" pm="."><plain>12741 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="823" pm="."><plain>MFN2 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="824" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="825" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="826" pm="."><plain>Santa Cruz </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="827" pm="."><plain>sc-100560 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="828" pm="."><plain>MFF </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="829" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="830" pm="."><plain>Rabbit polyclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="831" pm="."><plain>Abcam </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="832" pm="."><plain>ab81127 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="833" pm="."><plain>MRPL44 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="834" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="835" pm="."><plain>Rabbit polyclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="836" pm="."><plain>ProteinTech </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="837" pm="."><plain>16394-1-AP </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="838" pm="."><plain>MRPS18B </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="839" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="840" pm="."><plain>Rabbit polyclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="841" pm="."><plain>ProteinTech </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="842" pm="."><plain>15543-1-AP </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="843" pm="."><plain>Nanog </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="844" pm="."><plain>IF </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="845" pm="."><plain>Rabbit polyclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="846" pm="."><plain>Abcam </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="847" pm="."><plain>ab21624 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="848" pm="."><plain>ND1 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="849" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="850" pm="."><plain>Rabbit monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="851" pm="."><plain>Abcam </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="852" pm="."><plain>ab181848 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="853" pm="."><plain>ND2 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="854" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="855" pm="."><plain>Rabbit polyclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="856" pm="."><plain>Proteintech </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="857" pm="."><plain>19704-1-AP </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="858" pm="."><plain>ND3 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="859" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="860" pm="."><plain>Rabbit polyclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="861" pm="."><plain>Abcam </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="862" pm="."><plain>ab170681 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="863" pm="."><plain>ND4 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="864" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="865" pm="."><plain>Mouse polyclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="866" pm="."><plain>Abnova </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="867" pm="."><plain>H00004538-A01 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="868" pm="."><plain>ND4L </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="869" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="870" pm="."><plain>Rabbit Polyclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="871" pm="."><plain>LSBio </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="872" pm="."><plain>LS-C158368 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="873" pm="."><plain>ND5 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="874" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="875" pm="."><plain>Rabbit polyclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="876" pm="."><plain>Abcam </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="877" pm="."><plain>ab92624 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="878" pm="."><plain>ND6 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="879" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="880" pm="."><plain>Rabbit polyclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="881" pm="."><plain>Santa Cruz </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="882" pm="."><plain>SC-20667 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="883" pm="."><plain>NDUFB8 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="884" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="885" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="886" pm="."><plain>Abcam </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="887" pm="."><plain>ab110242 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="888" pm="."><plain>OPA1 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="889" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="890" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="891" pm="."><plain>BD Biosciences </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="892" pm="."><plain>612606 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="893" pm="."><plain>PEX19 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="894" pm="."><plain>IF </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="895" pm="."><plain>Rabbit monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="896" pm="."><plain>Abcam </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="897" pm="."><plain>ab137072 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="898" pm="."><plain>RAB5 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="899" pm="."><plain>IF </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="900" pm="."><plain>Rabbit monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="901" pm="."><plain>Cell Signaling </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="902" pm="."><plain>3547 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="903" pm="."><plain>SDHB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="904" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="905" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="906" pm="."><plain>Abcam </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="907" pm="."><plain>ab14714 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="908" pm="."><plain>SSEA3 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="909" pm="."><plain>IF </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="910" pm="."><plain>Rat monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="911" pm="."><plain>eBioscience </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="912" pm="."><plain>53-8833-71 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="913" pm="."><plain>SSEA4 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="914" pm="."><plain>IF </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="915" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="916" pm="."><plain>BD Biosciences </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="917" pm="."><plain>560219 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="918" pm="."><plain>TRA-1-81 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="919" pm="."><plain>IF </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="920" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="921" pm="."><plain>Millipore </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="922" pm="."><plain>MAB4381 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="923" pm="."><plain>TAT </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="924" pm="."><plain>WB/IF/IHC </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="925" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="926" pm="."><plain>Abcam </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="927" pm="."><plain>ab63957 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="928" pm="."><plain>TDP-43 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="929" pm="."><plain>WB/IF/IHC </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="930" pm="."><plain>Rabbit polyclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="931" pm="."><plain>ProteinTech </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="932" pm="."><plain>10782-2-AP </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="933" pm="."><plain>TDP-43 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="934" pm="."><plain>WB/IF/IHC </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="935" pm="."><plain>Rabbit polyclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="936" pm="."><plain>ProteinTech </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="937" pm="."><plain>12892-1-AP </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="938" pm="."><plain>TDP-43 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="939" pm="."><plain>WB/IF/IHC </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="940" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="941" pm="."><plain>ProteinTech </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="942" pm="."><plain>60019-2-Ig </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="943" pm="."><plain>TDP-43 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="944" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="945" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="946" pm="."><plain>Abnova </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="947" pm="."><plain>H00023435-M01 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="948" pm="."><plain>TDP-43 p409/410 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="949" pm="."><plain>WB/IF/IHC </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="950" pm="."><plain>Polyclonal antibody </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="951" pm="."><plain>ProteinTech </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="952" pm="."><plain>22309-1-AP </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="953" pm="."><plain>TIM22 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="954" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="955" pm="."><plain>Rabbit polyclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="956" pm="."><plain>ProteinTech </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="957" pm="."><plain>14927-1-AP </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="958" pm="."><plain>TIM23 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="959" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="960" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="961" pm="."><plain>BD Biosciences </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="962" pm="."><plain>611222 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="963" pm="."><plain>TOM20 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="964" pm="."><plain>WB/IF </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="965" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="966" pm="."><plain>BD Biosciences </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="967" pm="."><plain>612278 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="968" pm="."><plain>TOM70 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="969" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="970" pm="."><plain>Rabbit polyclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="971" pm="."><plain>ProteinTech </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="972" pm="."><plain>14528-1-AP </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="973" pm="."><plain>Ubiquitin </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="974" pm="."><plain>IF </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="975" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="976" pm="."><plain>Abcam </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="977" pm="."><plain>ab7254 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="978" pm="."><plain>UQCRC2 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="979" pm="."><plain>WB </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="980" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="981" pm="."><plain>Abcam </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="982" pm="."><plain>ab14745 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="983" pm="."><plain>VDAC1 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="984" pm="."><plain>WB/IF </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="985" pm="."><plain>Mouse monoclonal </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="986" pm="."><plain>Abcam </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="987" pm="."><plain>ab14734 </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>WB: western blot; IF: Immunofluorescence; IHC: Immunohistochemistry.</p></fn></table-wrap-foot></table-wrap></SecTag></floats-group></article>
